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Biologically-inspired materials have emerged as promising substrates for 
enhanced repair in various therapeutic and regenerative medicine applications, 
including nervous and vascular tissues, bone, and cartilage. These strategies 
focus on the development of materials that integrate well-characterized domains 
from biomacromolecules to mimic individual functions of the extracellular matrix 
(ECM), including cell adhesive motifs, growth factor binding sites, and protease 
sensitivity. A vital property of the ECM is the fibrillar architecture arising from 
supramolecular assembly. For example, the fibrillar structure of fibronectin (FN) 
matrices modulates cell cycle progression, migration, gene expression, cell 
differentiation, and the assembly of other matrix proteins. Current biomaterials do 
not actively promote deposition and assembly of ECM. In this research, we 
describe the rational design and investigation of non-fouling biomimetic surfaces 
in which an oligopeptide sequence (FN13) from the self-assembly domain of FN 
is tethered to non-fouling substrates. This surface modification directs cell-
mediated co-assembly of robust fibrillar FN and type I collagen (COL) matrices 
reminiscent of ECM, and increases in cell proliferation rates.  Furthermore, the 
effect of this peptide is surface-directed, as addition of the soluble peptide has no 
effect on matrix assembly.  We have also identified a critical surface density of 
the immobilized peptide to elicit the full activity.  These results contribute to the 
development and design of biomimetic surface modifications that direct cell 






The focus of this project was to engineer biomaterial surfaces that 
modulate cell-mediated assembly of extracellular matrices (ECM) in order to 
direct cell function.  The ECM plays a central role in tissue morphogenesis, 
homeostasis, and repair,1 and ECM characteristics are therefore worthy of 
mimicking to provide control of cellular activities on synthetic substrates.  
Biological macromolecules provide innovative recognition and structural motifs 
that have been engineered into substrates to create novel bio-functional mimetic 
materials.2,3  However, current materials displaying ECM characteristics, 
including cell adhesive motifs2,3 and growth factor binding sites4 do not 
reconstitute the fibrillar supramolecular structure of the natural ECM.  A vital 
property of the ECM is the fibrillar architecture arising from its supramolecular 
assembly.  The architecture of the natural ECM is responsible for its dynamic 
properties.  For example, the fibrillar structure of fibronectin (FN) matrices 
modulates cell cycle progression, migration, gene expression, cell differentiation, 
and the assembly of other matrix proteins.1,5-7  Current biomaterials do not 
actively promote deposition and assembly of ECMs.  The objective of this 
project was to engineer surfaces that promote the cell-mediated assembly 
of fibrillar FN.  Our central hypothesis was that a short peptide sequence 
(FN13) from the self-assembly domain of FN tethered to synthetic surfaces 
will promote cell-mediated fibrillar FN matrix assembly which will in turn 
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direct cellular activities.  This hypothesis was based on previous studies that 
have demonstrated that FN13 mediates assembly of FN and collagen (COL) 
matrices when added to the culture media of several cell types.  A significant 
advantage to our experimental system over previous studies is the use of model 
surfaces of self-assembled monolayers (SAMs) of alkanethiols on gold.  This 
system allows for the controlled presentation of immobilized ligands on a non-
fouling background, and coupled with robust biochemistry and bioengineering 
approaches, allows for rigorous analysis of the hypothesis. 
 
AIM 1:  INVESTIGATE FIBRONECTIN ADSORPTION AND CELL ADHESION 
TO MODEL NON-FOULING SUPPORTS.   
 FN adsorption and cell adhesion to CH3/EG3 mixed SAMs were 
investigated using ultra-sensitive techniques.  Differences in cell adhesion 
profiles arise from differences in the densities of adsorbed FN.   
 
AIM 2: ENGINEER MODEL BIOMIMETIC SURFACES THAT PROMOTE 
FIBRILLAR FN MATRIX ASSEMBLY.   
 The densities of tethered peptides were evaluated using ELISA and 
ellipsometry.  Both methods indicated that coating concentration (over a fixed 
time interval) controlled tethered peptide surface density, and that only 
background levels adsorbed non-specifically. FN matrix assembly was visualized 
by immunofluorescence staining, and quantified biochemically using Western blot 
analysis of detergent-insoluble fractions.  FN13-tethered surfaces showed the 
highest levels of assembled FN matrix compared to surfaces with tethered 
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peptides presenting scrambled sequences, and the current state-of-the-art 
adhesive peptide sequence, arginine-glycine-aspartic acid (RGD).   
 
AIM 3:  COMPARE CELL FUNCTIONS FOR CELLS CULTURED ON FN13-
TETHERED SUPPORTS TO CELLS CULTURED ON RGD-TETHERED AND 
UNMODIFIED SUPPORTS.   
 Only cells cultured on FN13-tethered surfaces assembled robust matrices 
with co-assembled FN and type I collagen.  The FN13-induced FN matrices were 
surface directed in that only surface bound peptides (not soluble in culture 
media) promoted FN matrix assembly.  Assembled FN matrices were completely 
composed of cell- secreted FN, opposed to FN from the culture media.  Cells 
cultured on these FN13-induced FN matrices also showed the highest levels of 
cell proliferation.   
 
THESIS OUTLINE 
 This thesis addresses the Specific Aims outlined above, and is organized 
in the following manner.  Chapter 2 provides background and significance of the 
field specific to this project.  Chapter 3 addresses topics in Specific Aim 1 and the 
findings described here were used in designing experiments to investigate 
Specific Aims 2 and 3.  Chapter 4 presents results addressing topics in Specific 
Aims 2 and 3.  Chapter 5 discusses the over all conclusions from the thesis work 
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BACKGROUND AND SIGNIFICANCE 
 
Biomaterials are central to numerous biomedical and biotechnological 
applications including contact lenses, vascular grafts, heart valves, and total joint 
replacements.  Initially, biomaterials were adopted from other areas of science 
and technology without significant redesign for medical use.1  These early 
biomaterials include silicones, polyurethanes, Teflon, nylon, titanium, and 
stainless steel.  While these early biomaterials filled a gap in medical technology, 
several limitations still existed.  Most significantly, immune responses to 
implanted materials resulted in chronic inflammation and poor host integration.2-6  
Next generation biomaterials consisted of polymers designed specifically for use 
as biomaterials.  Polyesters and polyamides were designed to decrease host 
immune responses and degrade in vivo through hydrolysis.  While these 
materials improved on select functions compared to their earlier counterparts, 
these polymers lack the ability to direct cell function and mimic the natural 
extracellular environment.  Recent advances in biomaterial science include the 
development of biomimetic materials.7-10  This class of biomaterials incorporates 
bioactive motifs from biological macromolecules to control cell function.  While 
some of these recently developed biomaterials mimic the natural extracellular 
matrices (ECM) through the incorporation of numerous bioactive domains, they 
do not mimic the spatial and temporal resolution of the natural ECMs.  There is 
an evident need for further advances.   
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EXTRACELLULAR MATRIX: NATURE’S BIOMATERIAL SCAFFOLD 
Native Extracellular Matrix 
The ECM is a dynamic network of proteins and polysaccharides secreted 
and assembled locally by cells.11  ECMs are constantly undergoing remodeling to 
maintain the structure and presentation of protein ligands and growth factors.  
The complex organization of matrix-assembled proteins provides structural 
support to cells within tissues while also providing signaling cues vital for cellular 
regulation, development, migration, proliferation, shape and function.11-18  
Important structural proteins of the ECM include collagen (COL) and elastin, 
while the adhesive components include fibronectin (FN), vitronectin (VN), and 
laminin (LN).  Each of these ECM proteins has domains to which cells adhere.  
Cells adhere to the ECM using a class of transmembrane proteins called integrin.   
FN was the first identified cell-adhesive protein, and is one of the best 
characterized.19-23  FN is a large multi-domained glycoprotein found on cell 
surfaces, in blood and body fluids, and in the ECM (Figure 2.1).  FN is secreted 
by cells as a large soluble dimer (220 kDa each), and is assembled within the 
ECM into a fibrillar high molecular weight insoluble multimer.24  As demonstrated 
in a FN-knockout study in mice, FN is essential for embryonic development.25  
Furthermore, integrin (specifically, α5β1) mediated adhesion to FN regulates 
osteoblast survival and expression of osteoblast-specific genes and matrix 
mineralization, as well as myoblast differentiation, in vitro.26-28  Matrix assembled 
FN modulates cell cycle progression, migration, gene expression, cell 





FIGURE 2.1  Schematic model of FN domain structure.   This cartoon illustrates 
the organization of repeating structural domains I ( ), II ( ) and III ( ),and the 
variable region, V, ( ), the amine and carboxy termini and the disulfide-bridge site 
of dimerization.  Highlighted domains include binding sites for fibrin, collagen, FN 
(self-assembly), and heparin, as well as the central cell binding domain (CCBD) 
that includes the RGD binding motif and the PHSRN synergy site.  Also 
highlighted, with shading are domains that have identified roles in FN matrix 
assembly.  
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FN Matrix Assembly 
The ECM plays a central role in tissue development, homeostasis, blood 
clotting, wound healing, and cancer metastasis.30-33  A critical property of ECMs 
is the assembly of supramolecular structures.  The architecture of the natural 
ECM is responsible for its dynamic properties.30  Matrix assembled FN modulates 
cell cycle progression, migration, gene expression, cell differentiation, and the 
assembly of other matrix proteins.11-18,29  Matrix assembly of FN involves a 
complex series of cell mediated events (Figure 2.2) that begins with the cellular 
secretion of soluble FN dimers, and involves the binding of multiple integrin 
receptors (α5β1, and αvβ3) to them.19,24,34,35  Through cytoskeletal induced tension 
and receptor motility, FN is assembled into a network of insoluble fibrils stabilized 
through disulfide cross-linking.35-38  Cell-induced tension on FN creates 
conformational changes within individual domains.39  The conformational 
changes within FN expose normally buried amino acid sequences, often called 
“cryptic domains.”  These newly exposed domains are critical for the presentation 
of integrin binding sequences and FN-FN binding domains; which are 
responsible for the robustness of ECMs formed by co-assembled proteins.40-44   
The development of recombinant FN proteins and the use of integrin- and 
FN-blocking antibodies has been significant in the isolation of FN self-assembly 
domains (Figure 2.1).  Several regions of FN play a role in the assembly of 
fibrillar FN matrices.24,45  The first five type I repeats,15,46 the RGD cell-binding 
domain,35 the synergistic cell adhesive region,34,47 the alternatively spliced V 
region,48  the heparin II binding domain,49 the type I7-9 COL binding domain which 
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FIGURE 2.2  Cell induced FN matrix assembly.  This cartoon depicts the 
systematic assembly of FN matrices, which begins with integrin binding to FN 
dimers.  Integrin binding of FN initiates intracellular focal adhesion formations, 
followed by integrin motility along assembled actin filaments creates tension on 
FN fibrils that exposes cryptic FN-FN binding domains.  Finally, exposure of FN-
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stabilizes FN fibrils,50 and an FN-FN binding site in a 14-kDa FN fragment 
containing the first two type III repeats have all been identified to influence FN 
matrix assembly.51,52  The smallest identified sequence of amino acids within FN 
shown to promote FN matrix assemble is a 13-amino acid stretch (FN13) 
spanning between the type II2 and I7 repeats.53  Culture media supplemented 
with several of these sequences regulate cell functions such as matrix assembly, 
adhesion, migration, proliferation, and the co-assembly of other matrix proteins 
such as COL.16,53,54 
 
ECM MIMETIC MATERIALS 
The most significant recent advances in the development of biomaterials 
have been the development of biomimetic materials.  These biologically inspired 
materials are characterized by their ability to interact specifically with their 
environment to elicit a natural biological response.  Biomimetic materials have 
emerged as promising substrates for enhanced repair in various therapeutic and 
regenerative medical applications, including nervous and vascular tissues, bone, 
and cartilage.55,56 These strategies focus on the development of materials which 
integrate well-defined domains from biomacromolecules to mimic individual 
functions of the ECM, including cell adhesive motifs,10 growth factor binding 
sites,57 and protease sensitivity.58   
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Materials Presenting Cell Adhesive Motifs 
Pioneering work has identified domains of adhesive proteins present in the 
ECM, such as the arginine-glycine-aspartic acid (RGD)59 motif present in FN, the 
tyrosine-isoleucine-glycine-serine-arginine (YIGSIR) sequence in laminin,60 and 
the glycine-phenylalanine-hydroxyproline-glycine-glutamate-arginine (GFOGER) 
oligo-peptide in collagen (COL).61,62  Since then, numerous groups have 
covalently attached or physisorbed these bioadhesive peptides to substrates and 
scaffolds to promote receptor-mediated cell adhesion and migration in various 
cell types.1,8,63-66  The density and distribution of adhesive ligands are important 
for cell adhesion, integrin clustering, cell migration, and differentiation.67-71  
Numerous studies have shown that there is a critical density of RGD peptide on 
non-adhesive backgrounds for initial cell attachment.72-75  Massia and Hubbell 
have shown that 4 x 105 molecules of RGD per cell were required to promote cell 
adhesion, integrin clustering and focal adhesion.73  Peptide density-dependent 
responses are also important for cell activity and differentiation in numerous cell 
types including osteoblasts and myoblasts.70,76-78  Rezania and Healy have 
shown that  surface-bound RGD-containing peptides enhance mineralization of 
osteogenic cells compared to control RGE-presenting surfaces, and unmodified 
surfaces.70   
Although short bioadhesive peptides attached to synthetic surfaces 
increase cell adhesion, the biological activity of these peptides is significantly 
lower than that of complete proteins due to the absence of complementary 
domains.79,80  Furthermore, short amino acid sequences (RGD) lack cellular 
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specificity due to its presence in numerous adhesive proteins,59 and the ability of 
numerous cell types to recognize that sequence with multiple integrin receptors.  
Furthermore, the deposition of ECM is significantly reduced in cells cultured on 
substrates functionalized with increasing densities of RGD containing peptides.81 
 
Materials Presenting Growth Factors/ Growth Factor Binding Sites 
Growth factors are extracellular polypeptide signaling molecules that 
stimulate cell proliferation and differentiation.  Natural ECMs bind soluble growth 
factors and regulate their stability, presentation, and delivery to cells.31,32,82 The 
biological activity of the growth factor depends on its presentation in space and 
time.63  Biomaterials can mimic this event using three different strategies, (1) 
direct immobilization,83-85 (2) tethering via immobilized heparin,86-88 and (3) 
immobilization via a heparin bridge to heparin binding motifs89,90 (for review57).  
While some researchers rely on proteolytic release of immobilized growth factors 
from biomaterial surfaces,85,91-93 others have shown that immobilized growth 
factors are as active as the soluble form.84,87,94  Growth factor ligands 
immobilized through heparin binding domain, or programmed to release 
enzymatically most closely resemble the mechanism of the natural ECM.32,82  
The incorporation of growth factors within scaffolds by any of the above-




Materials Incorporating Protease Sensitive Sites 
Major enzymes, including matrix metalloproteinase, regulate the ECM 
structure by removing excess components, remodeling the structure, and 
releasing growth factors during growth, morphogenesis, and tissue repair.95,96  
Cells migrate through the ECM via the proteolytic degradation of matrix proteins 
to clear pathways for movement.8  Proteolytic cleavage domains incorporated 
into the framework of biomaterials allow cells to mimic this behavior, while 
promoting cell infiltration and migration.58,97-100  Cell adhesive ligands can also be 
incorporated55,75,101 into materials with proteolytic domains, which serve the role 
of releasing growth factors to migrating cells.102  The extent of migration and cell 
infiltration depends on the protease-substrate activity, adhesion ligand 
concentration, and the density of cross-links in the material.103   
While there have been numerous attempts to mimic the functions of the 
ECM, little work has been directed towards promoting the assembly of cell 
mediated matrices.  Pernodet and colleagues have developed sulfonated 
polystyrene surfaces which mediate FN fibrillogenesis.104  While it is evident that 
the FN in this study was fibrillar, there was no investigation of its biochemical 
integrity, or the ability of the FN to mediate cellular responses.  Cellular 
assembled ECMs incorporate all of the previously mentioned bioactive domains 
(Figure 2.1) while controlling the spatial distribution of each element to optimize 
cell function.  Synthetic biomaterials prepared to date do not mimic the complete 
function of the natural ECM.  Even though considerable advances have been 
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made to mimic specific functions of the natural ECM, there is clearly a need for 
further advances to recreate the functions of natural ECMs.   
 
CELL ADHESION TO SYNTHETIC MATERIALS 
Cell adhesion to synthetic surfaces is critical to numerous biomedical and 
biotechnological applications.3,105,106  Biomaterials elicit host responses when 
implanted into living tissues (for review2).   In most instances, specific binding of 
cellular receptors to proteins adsorbed onto material surfaces mediate cell-
material interactions.  For example, many proteins, including immunoglobulins, 
fibrinogen, and FN, adsorb onto implant surfaces upon contact with physiological 
fluids.107-109  These adsorbed proteins mediate the adhesion and activation of 
platelets, neutrophils, and macrophages which in turn modulate subsequent 
inflammatory responses.110-112  Because of the central role of protein adsorption 
in cell adhesion, inflammation, and tissue formation, extensive research efforts 
have focused on the control of protein adsorption to synthetic surfaces.   
 
Protein Adsorption to Synthetic Surfaces 
Numerous studies have shown that the type, quantity, and structure of 
adsorbed proteins are influenced by the underlying substrate.113-118  Surfaces 
that readily adsorb proteins from solution often offer little control over the type or 
quantity of protein adsorbed, resulting in lack of specificity.  Passively adsorbed 
proteins undergo a range of processes including a dissociation from the surface 
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and return to solution, change in orientation, changes in conformation/structure 
with retention of biological activity, conformational changes resulting in loss of 
activity, or exchange with other proteins from the solution.119  García et. al. have 
shown that substrates with controlled surface chemistries modulate the 
functionality of adsorbed FN.116,118  These changes in adsorbed FN structure 
modulate cell adhesion and higher order cell activities, including myoblast and 
osteoblast proliferation and differentiation.28,118,120,121  While passive adsorption of 
proteins to coat surfaces can offer control over the presentation of proteins to 
cells in a controlled in vitro experiment, protein coated surfaces may elicit a wide 
range of responses in vivo.  Non-fouling chemistries offer an alternative strategy 
for biomaterial surface modifications to both create protein resistant surfaces, 
and to decrease host responses to implanted devices. 
 
Non-Fouling Protein Resistant Surfaces 
Surface chemistries that prevent protein adsorption and render surfaces 
non-adhesive have emerged as promising biomaterial modifications for 
minimizing host-implant inflammatory responses and providing a non-specific 
background for the presentation of bioactive motifs to elicit specific cellular 
responses.75,122-130  It is generally accepted that surfaces that readily adsorb 
proteins will support cell adhesion while surfaces that resist protein adsorption 
will prevent cell attachment.  As a general rule, hydrophobic surfaces promote 
protein adsorption while hydrophilic surfaces resist protein adsorption.  Common 
methods to create non-fouling protein resistant materials include adsorption or 
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grafting of carbohydrates (agarose131, mannitol132), proteins (albumin133), or 
synthetic polymers (poly-(ethylene glycol (EGn),134 polyacrylamide135) onto the 
surfaces of the material.  Each of these techniques has distinct advantage and 
disadvantages.  For example, albumin adsorption to surfaces represents a 
simple method to decrease initial cell adhesion, but adherent cells are able to 
remodel surface proteins and deposit their own adhesive matrix proteins.131  
Albumin can also be displaced from surfaces by other adhesive proteins in 
solution.  While carbohydrates often offer longer stability in their ability to retain 
non-fouling properties,132,136 small molecule synthesis of these complex 
functional groups is often more laborious than the simple repeating units of non-
fouling polymers (i.e. EGn, (OCH2CH2)n).  However, monolayers of short EG 
containing alkanethiols lose their ability to resist protein adsorption and cell 
adhesion after seven days in culture.132  Like most other polyethers, EG 
containing polymers are subject to oxidative degradation and chain cleavage.137  
Over time, this decrease in EG chain length results in decreases in the ability to 
resist both protein deposition and cellular infiltration.  Increasing the number of 
EG repeat units significantly increases the stability of EG functionalized materials.  
While surface modifications have been very successful in vitro to prevent protein 
adsorption and cell adhesion, there is often little correlation between in vitro and 
in vivo studies.   For example, Park et. al. showed that grafting EG polymers to 
several biomaterials (including Nitinol stents, glasses, and silicon rubber) 
reduced protein adsorption and platelet adhesion by nearly 95% compared to 
unmodified surfaces in vitro.138  However, in the same study, only moderate 
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improvements were evident in vivo (~30% decreases in platelet adhesion).  The 
authors attribute these discrepancies to the extent of tissue damage during 
implant surgery.  While it is important to have flexibility in choosing the correct 
non-fouling chemistry for the desired application, EG functionalized materials are 
often considered the standard in protein resistant non-fouling surface 
modifications for their ease of synthesis and robust non-fouling properties, and 
are currently used in several in vivo applications.114,129,139,140   
 
MODEL SUBSTRATES: SELF-ASSEMBLED MONOLAYERS 
Model substrates with well-controlled surface properties represent useful 
tools for the analysis of surface-protein-cell interactions.  In particular, self-
assembled monolayers (SAMs) of alkanethiols on gold have provided a robust 
system to systematically investigate the effects of surface chemistry on protein 
adsorption without altering other surface properties such as roughness.114,119,141-
147  ω-functionalized, long-chain alkanethiolates (HS-(CH2)n-X, n ≥ 10) 
spontaneously assemble from solution onto gold surfaces to form stable, well-
packed and ordered monolayers.148-151  The physicochemical properties of these 
monolayers are controlled by the tail group, X.152,153  Through the use of straight 
forward synthetic chemistry, the terminal X group of the alkanethiols can be 
modified to create model systems to study interaction such as wetting,151,154-157 
surface initiated polymerization,158,159 protein adsorption,132,160-163 fibrin 
polymerization,164 and cell attachment and adhesion.128,134,165-168  Recently, 
SAMs have also been used as model systems for the design of biosensors, and 
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nanoscale switchable surfaces.169-175  The simplicity of creating surfaces 
presenting wide ranges of chemistry makes SAMs an attractive method for 
studying interfacial interactions for numerous applicatoins. 
 
Quantification of Surface Ligand Density 
Due to both the organic composition of SAMs and the reflective gold 
substrates, numerous analytical techniques are available to quantify the density 
of SAM surface ligands (peptides/ proteins) on the surface.  The most common 
methods to measure surface ligand density include ellipsometry, surface 
plasmon resonance (SPR), enzyme linked immunosorbent assays (ELISA), 
direct radiolabeling of ligands, and fluorescent labeling.  Ellipsometry and SPR 
are powerful analytical techniques that were quickly adapted to SAMs because of 
the reflective nature of the gold substrates.  Ellipsometry is used to measure the 
film thickness of dried samples by characterizing the change in refractive index of 
the surfaces after exposure to protein (or peptide) solutions.  Changes in film 
thickness can be reproducibly measured with sensitivity of less and 1 Å.  
Whitesides and colleagues used this method exclusively in early studies 
characterizing proteins adsorption to SAM surfaces.146  This method takes 
representative scans of small sample areas and assumes uniform distribution of 
ligands on the SAM surface.  Because the samples are removed from solution, 
rinsed, and dried prior to analysis, weak and reversibly bound ligands may not be 
detected, which can lead to inaccurate measurements.  However, with know 
elliptical constants this technique offer the ability to convert changes in film 
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thickness to absolute surface density on an undisturbed (without labeling the 
protein of interest).176 
SPR is an attractive method for the analysis of ligand density since 
measurements can be made in real time in solution.177  Samples are inserted into 
a flow chamber where they are exposed to ligand containing solutions.  These 
chambers allow for the instantaneous measurements of adsorbates, and are 
powerful tools for measuring the kinetics of binding phenomena.  However, 
surfaces that are determined to be protein resistant using these techniques are 
often shown to support cell adhesion.126,161  These inconsistencies were most 
likely due to instrumental limitations.  The sensitivity of SPR is ~2.0 ng/cm2.127   
García et. al. have previously reported using radio-labeled FN that 0.2 
ng/cm2 is sufficient to mediate robust cell adhesions.120,163,178  While direct radio-
labeling of ligands yields the most sensitive measurements (sensitivity of >0.01 
ng/cm2).178-180  High background signals (i.e. low signal-to-noise) can be 
associated with 125I measurements if remaining free iodine is not removed from 
the ligand solution since iodine also has a high affinity for gold.   
Another technique commonly used to measure surface ligand density is 
ELISA.  While this technique offers high specificity and accuracy of 
measurements, it provides only a relative measure of ligand density.  In addition, 
when measuring the density of small peptide ligands, it is possible for the 
antibodies to saturate the surface before the significantly smaller immobilized 
ligands (Capadona, unpublished results).  However, ELISAs are ideal for 
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surveying multiple samples in short time intervals, and are thus an attractive 
technique.   
Finally, detection of fluorescently labeled ligands is a promising area that 
is currently being expanded.  While labeling of ligands with fluorescent tags prior 
to introduction to the surfaces yields high specificity and throughput, the 
limitations to this system include auto-quenching of fluorescence, decrease 
sensitivity (compared to radio-labeling), and difficulties in accurately determining 
a standard.  Furthermore, labeling small peptides with large fluorescent tags may 
also alter the surface-tethering (Capadona, unpublished results).  While no single 
technique is ideal for all applications, there are significant advantages to the 
flexibility of several distinct methods of analysis of surface associated ligands. 
 
EGn-Containing SAMs and Protein Resistance 
While numerous functional groups can be used to minimize protein 
adsorption to SAM surfaces, the EGn group remains the standard for comparison 
(for summary/ review181).  Extensive effort has focused on the characterization of 
the non-fouling properties of EGn functionalized surfaces; including the 
mechanism for protein resistance.  Andrade and coworkers have proposed that 
surfaces modified with EGn retain protein resistance through “steric 
stabilization.”182,183  In aqueous solutions, the EGn chains are highly solvated due 
to the high binding affinity for water,184 and it is this interfacial layer of water that 
is suspected to repel soluble proteins.  Through molecular modeling, and by 
controlling the surfaces packing density of EGn functionalized alkanethiols in 
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monolayer, Grunze and Whitesides have shown that helical orientation of EGn in 
monolayer influences the protein resistant properties by increasing the EGn-water 
binding.184-186  This unique property of EGn functionalized alkanethiols allows for 
low surfaces densities of EGn to retain the non-fouling surface properties.114,146  
These dynamic interactions between EGn, water, and proteins create a powerful 
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FIBRONECTIN ADSORPTION AND CELL ADHESION TO MIXED 




Surface chemistries that prevent protein adsorption and render surfaces 
non-adhesive have emerged as promising biomaterial modifications for 
minimizing host-implant inflammatory responses and providing a non-specific 
background for the presentation of bioactive motifs to elicit directed cellular 
responses.  Oligo(ethylene glycol) moieties [-(CH2CH2O)n-, abbreviated as EGn] 
have proven to be the most protein-resistant functionality and remain the 
standard for comparison.  In the present study, we analyzed fibronectin (FN) 
adsorption and cell adhesion to CH3/EG3 mixed self-assembled monolayers.  In 
contrast to previous studies with ellipsometry and surface plasmon resonance 
spectroscopy, we demonstrate significant radiolabeled FN adsorption onto EG3-
containing surfaces, including pure EG3 monolayers.  These FN-coated surfaces 
supported FN density-dependent increases in fibroblast adhesion strength.  
However, while FN adsorbed irreversibly to CH3-terminated surfaces, adsorbed 
FN was removed from EG3 monolayers and the corresponding cell adhesion 
eliminated by long-term (16 h) incubation in either protein-free or serum-
containing solutions.  Once the adsorbed FN was eluted, EG3 monolayers 
remained non-adhesive, even in the presence of serum-containing media.  These 
*Capadona, J.R., Collard, D.M. and García, A.J.  Langmuir. 19(5):1847-1852. (2003). 
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Cell adhesion to synthetic surfaces is critical to numerous biomedical and 
biotechnological applications, including biomaterials, tissue engineering, and in 
vitro culture substrates.1-3   In most instances, cell-material interactions are 
mediated by specific binding of cellular receptors to proteins adsorbed onto 
material surfaces.  For example, many proteins, including immunoglobulins, 
fibrinogen, and fibronectin (FN), adsorb onto implant surfaces upon contact with 
physiological fluids.4-6  These adsorbed proteins mediate the adhesion and 
activation of platelets, neutrophils, and macrophages which in turn modulate 
subsequent inflammatory responses.7-9   Because of the central role of protein 
adsorption in cell adhesion, inflammation, and tissue formation, extensive 
research efforts have focused on the analysis of protein adsorption to synthetic 
surfaces.  Numerous studies have shown that the type, quantity, and structure of 
adsorbed proteins are dynamically influenced by the underlying substrate.10-14  Of 
particular importance, surface chemistries that prevent protein adsorption and 
render surfaces non-adhesive have emerged as promising biomaterial 
modifications for minimizing host-implant inflammatory responses and providing 
a non-specific background for the presentation of bioactive motifs to elicit specific 
cellular responses.15-20 
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Model substrates with well-controlled surface properties represent useful 
tools for the analysis of surface-protein-cell interactions.  In particular, self-
assembled monolayers (SAMs) of alkanethiols on gold have provided a robust 
system to systematically investigate the effects of surface chemistry on protein 
adsorption without altering other surface properties such as roughness.11,21  ω-
functionalized, long-chain alkanethiolates [HS-(CH2)n-X, n ≥ 10] spontaneously 
assemble from solution onto gold surfaces to form stable, well-packed and 
ordered monolayers.22  The physicochemical properties of these monolayers are 
controlled by the tail group, X.  Early work demonstrated the general trend that 
hydrophobic tail groups enhance protein adsorption while neutral hydrophilic 
groups exhibit reduced protein adsorption.11,23  Oligo(ethylene glycol) moieties [-
(CH2CH2O)n-, abbreviated as EGn] have proven to be the most protein-resistant 
functionality and remain the standard for comparison.11,24,25  Using mixed 
monolayers of methyl- and EGn-terminated alkanethiols, Prime and Whitesides 
demonstrated that, above a critical surface density of EGn, surfaces effectively 
resist protein adsorption as determined by ellipsometry and longer EG repeats 
prevent protein adsorption at lower mole fractions in the monolayer.24  Leckband 
and colleagues showed that although EGn-SAMs with n≥3 resisted protein 
adsorption from serum-containing media as measured by surface plasmon 
resonance (SPR), these monolayers supported significant levels of fibroblast 
adhesion which decreased with increasing EG chain length.26  This study 
indicated that EGn moieties can support cell adhesion, presumably by adsorbing 
adhesive proteins from serum, and contrasts with a large body of literature 
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documenting the effectiveness of short EGn (n=3-6) groups in preventing protein 
adsorption and cell adhesion in micropatterning applications.21,27,28   It is 
important to point out that the protein measurement techniques used in most of 
these studies (ellipsometry, SPR) have limited sensitivity and protein densities 
below the detection limit of these methods (~2 ng/cm2 reported for SPR26) have 
been shown to support robust cell adhesion.29,30  In the present study, we used 
radiolabeled FN to analyze protein adsorption onto mixed monolayers of methyl- 
and EG3-terminated alkanethiols.  We demonstrate that EG3-terminated SAMs 
support FN adsorption at levels that mediate cell adhesion.  Unlike CH3 SAMs, 
the adsorbed FN can be eluted from the EG3 monolayers and the corresponding 
cell adhesion eliminated by long term (16 h) incubation in protein-free or serum-
containing solutions.  These results provide new insights into our understanding 




 Murine NIH3T3 fibroblasts (CRL-1658) were obtained from ATCC 
(Manassas, VA) and maintained in Dulbecco’s modified Eagle’s medium (DMEM) 
supplemented with 10% newborn calf serum (NCS), penicillin (100 units/mL), and 
streptomycin (100 mg/mL).  Cell culture reagents, including human plasma FN 
and Dulbecco’s phosphate buffered saline (PBS), were purchased from Life 
Technologies (Rockville, MD).  Newborn calf serum was obtained from HyClone 
(Logan, UT).  Calcein-AM fluorescent dye was obtained from Molecular Probes 
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(Eugene, OR).  All starting materials for synthesis, 1-dodecanethiol (HS-(CH2)11-
CH3), and all other chemical reagents were used as received from Aldrich 
Chemical Company (St. Louis, MO).  Bolton Hunter Reagent was purchased 
from NEN Life Sciences (Boston, MA). 
 
Methods 
Synthesis of HS-(CH2)11-EG3-OH 
Tri(ethylene glycol)-terminated alkanethiol (HS-(CH2)11-(EG)3OH) was 
synthesized (Scheme 3.1) as previously described31 and characterized by 1H- 
and 13C-NMR, Fourier transformed infrared spectroscopy, and mass 
spectroscopy. 
 
Undec-1-en-11-yltriethlene glycol (1)   
A mixture of tri(ethylene glycol) (35.20 g, 234.7 mmol) and 3.75 mL of 
50% NaOH was refluxed for 0.5 h at 100 oC under an atmosphere of nitrogen 
and  11- bromoundec-1-ene (10.40 ml, 47.4 mmol) was added.  The mixture was 
refluxed for 24 h, cooled and extracted with hexane (6 x 50 mL).  The hexane 
extracts were combined and the solvent was evaporated under reduced pressure 
to afford a yellow oil.  The oil was purified using chromatography (silica gel; gel 1 
of ethyl acetate, followed by gel 2 of 19:1 CHCl3/MeOH) to give 5.71 g (79%) of 
monoether (1):  1H NMR (300 MHz, CDCl3) δ1.2 (br m, 12 H, alkane), 1.55 (qui, 
2H, J = 7 Hz, C-10), 1.95 (q, 2H, J = 7 Hz, C-3), 2.85 (br s, 1H, C-OH), 3.35 (t, 
2H, J = 7 Hz, C-11), 3.6 (m, 12 H, OCH2CH2O), 4.85 (qq, 2H, J = 3.3, 1.65, C-1),  
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SCHEME 3.1. Conditions; a) Tri(ethylene glycol), 50% NaOH, 100 oC, 0.5 h; 11-
bromoundec-1-ene, 100 oC, N2, 24 h. b) AIBN, Thiolacetic acid, dry THF, over night, 






















5.75 (qt, 1H, J = 7, 3.3, C-2);  13C NMR (75 MHz, CDCl3) δ139.02, 113.98, 72.42, 
71.40, 70.46, 70.20, 69.87, 61.52, 33.65, 29.43, 29.38, 29.28, 28.96, 28.76, 
25.91; MS (CI, ammonia), M+1 303.2, M+18 320.3;   IR (neat, cm-1) vmax 3459.78 
(C-OH), 3070.83 (C=C H-stretching), 2854.74 (CH2 symmetric), 1463.15 (CH2 
scissoring) , 1126.05 (C-O stretch).  
 
[1-[(Methylcarbonyl)thio]undec-11-yl]-tri(ethylene glycol)  (2)   
Undec-1-en-11-yltriethlene glycol (1) (1.0g, 3.3 mmol) was added to a 
solution of thiolacetic acid (0.94 mL, 13.2mmol) and AIBN 0.15 g, 0.91 mmol) in 
dry THF (8.25 mL) and the mixture was irradiated overnight under an 
atmosphere of nitrogen with a 450-W medium pressure mercury submersion 
lamp.  The solvent was removed on a rotorary evaporator to give crude product.  
The oil was purified using chromatography (silica gel; 30:1 CH2Cl2/ MeOH) to 
give thioacetate 2 at 79%:  was used without further purification; 1H NMR (300 
MHz, CDCl3) δ1.2 (br s, 12 H, alkane), 1.6 (m, 4 H, C-9, C-10), 2.33 (s, 3 H, -
CH3), 2.85 (t, 2 H, J = 7 Hz, C-1), 3.45 (t, 2 H, J = 7 Hz, C-11), 3.6-3.8 (m, 12 H, 
OCH2CH2O);  13C NMR (75 MHz, CDCl3) δ 72.42, 71.40, 70.46, 70.20, 69.87, 
61.52, 33.65, 29.43, 29.38, 29.28, 28.96, 28.76, 25.91; MS (CI, ammonia), M+1 
379.2;  IR (neat, cm-1) vmax 3455.46 (C-OH stretch), 2928.21 (CH2 asymmetric 
stretch), 2850.42 (CH2 symmetric stretch), 2245.38 (S-C=0-CH3), 1467.47 (CH2 
scissoring), 1350.78 (CH2 wagging), 1247.06 (out of plane bending), 1108.76 (C-
O), 732.77 (C-S-C).  
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(1-Mercaptoundec-11-yl)tri(ethylene glycol)  (HS-11-(EG)3OH, 3)   
Thioacetate 2 was dissolved in 0.4 M HCl in MeOH, and the mixture was 
stirred at room temperature for 4-5 d under nitrogen.  Solvent was removed and 
the crude product was purified using chromatography (silica gel; 8:8:1 EtAc/ 
CH2Cl2/ MeOH) 86% yield; 1H NMR (300 MHz, CDCl3) δ 1.1 ( br s, 14 H, alkane), 
1.2 (t, 1 H, J= 7 Hz, C-SH), 1.5 (m, 4 H, C-9, C-10), 2.5 (q, 2 H, J = 7, C-1), 3.0 
(br s, 1 H, C-OH), 3.4 (t, 2 H, J = 7, C-11), 3.5-3.75 (m, 12 H, OCH2CH2O); 13C 
NMR (75 MHz, CDCl3) δ 72.51, 71.54, 70.53, 70.28, 69.96, 61.67, 33.98, 29.51, 
29.45, 29.00, 28.31, 26.00, 24.59;  MS (EI) M+1 337,  IR (neat, cm-1) v max 
3451.14 (C-OH stretch), 2923.89 (CH2 asymmetric stretch), 2850.42 (CH2 
symmetric stretch), 2560.86 (S-H stretch), 1467.47 (CH2 scissoring), 1350.78 
(CH2 wagging), 1294.60 (CH2 twisting), 1130.37 (C-O stretch), 724.13 (CH2 
rocking). 
 
Preparation of Substrates and Monolayer Formation.   
Glass coverslips (9 mm2) were cleaned in 70% H2SO4/30% H2O2 for 1 h at 
90oC, rinsed with diH2O, then EtOH, and dried under a stream of N2.  Lab-Tek 
16-well chamber slides (Nalge Nunc, Naperville, IL) were cleaned by oxygen 
plasma etching for 3 min in a barrel etcher (LFE Plasma Systems, Clinton, MA).  
All substrates were coated with 50 Å Ti, then 150 Å Au using a Thermionics VE-
100 electron beam evaporator (Modesto, CA).   To assemble CH3/EG3 mixed 
monolayers, Au-coated samples were immersed in ethanolic solutions containing 
mixtures of the two alkanethiols.  The mole fractions of the two thiols were varied 
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while the total alkanethiol solution concentration was maintained constant at 2 
mM.  For contact angle and X-ray photoelectron spectroscopy (XPS) 
characterization, SAMs were immersed in alkanethiol solutions for 10 h.  For all 
other experiments unless noted, monolayers were assembled for 4 h.  After 
immersion in alkanethiol solutions, samples were rinsed in EtOH and dried under 
a stream of N2 prior to use.   
 
Contact Angle Measurements.   
Ambient air-water-surface contact angles for SAMs comprising varying 
EG3 mole fractions were measured as described previously.32,33 Briefly, a 5 µL 
drop of diH2O was placed on the surface and advancing contact angles were 
measured from opposite edges of the drop using a Ramé-Hart model #100-00 
goniometer (Mountain Lakes, NJ) fitted with a digital camera and analyzed using 
in-house image analysis software.   
 
X-ray Photoelectron Spectroscopy (XPS).   
XPS analysis was carried out with a Surface Science Model SSX-100 with 
small spot ESCA spectrometer.  SAMs were prepared as described above using 
solution mole fractions ranging from 0 to 1.0 in increments of 0.1.  Survey scans 
for S, C, and O were first obtained for elemental analysis of the surface.  Detailed 
scans for O1s and C1s were obtained for each surface composion.  Surface 
mole fractions for EG3 (χEG3) were calculated as the ratio of the intensity of the 
O1s peak for the sample to the intensity of the O1s peak for pure EG3 SAM. 
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FN Adsorption Measurements.   
FN adsorption to SAMs was quantified using 125I-labeled FN.  FN was 
iodinated using the Bolton-Hunter Reagent as described previously.13,30  Briefly, 
the Bolton-Hunter Reagent was concentrated in the reaction vessel by 
evaporating the benzene solvent under a stream of N2.  FN (100 µg, 10 µg/mL in 
0.1 M sodium borate, pH = 8.5) was added and incubated overnight at 4oC.  The 
coupling reaction was quenched with 50 µL of 0.2 M glycine in 0.1 M sodium 
borate.  Labeled FN (125I-FN) was purified by size exclusion chromatography 
using a Sephadex G-25 column.  The column was blocked overnight with 1% 
bovine serum albumin (BSA) prior to use.  125I-FN fractions were pooled and 
stored at 4oC.  Specific activity (1.9 x 106 cpm/µg) was determined with the 
NanoOrange Protein Quantification Kit (Molecular Probes) along with 
measurements of radioactivity using a COBRA II Auto Gamma Counter (Packard 
Bioscience, Meridien, CT).  To demonstrate that the iodination procedure did not 
alter the activity of the protein, control adsorption experiments with different ratios 
of labeled and unlabeled protein were performed. 
For this and all subsequent experiments, mole fractions reported for SAMs 
were surface composition as determined from XPS analysis.  SAMs were 
assembled on Au-coated 9 mm2 glass cover slips and pre-soaked in diH2O for 30 
min.  Samples were then immersed in 125I-FN solutions (mixed with unlabeled FN 
in PBS) for 1 h.  After removing FN solutions, samples were immersed in 1% 
BSA for 1 h.  Samples were transferred to clean tubes and radioactivity was 
measured using a gamma counter.  Adsorbed 125I-FN was quantified as 
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radioactive counts (cpm) and converted to adsorbed FN surface densities 
(ng/cm2).  For FN elution studies, samples were coated with FN and BSA as 
described above, then incubated in PBS or 10% NCS in DMEM for 1 h or 16 h, 
and the remaining FN adsorbed on the sample was quantified. 
 
Cell Adhesion Assay.   
Cell adhesion to SAMs was measured using a centrifugation assay that 
applies well-controlled detachment forces.32,34  SAMs were assembled in Au-
coated Lab-Tek chamber slides and incubated in different FN concentrations for 
1 h and then blocked in 1% BSA for 1 h to prevent non-specific adhesion.  
NIH3T3 fibroblasts were labeled with 2 µg/mL calcein-AM and seeded at 200 
cells/mm2 in 10% NCS in DMEM onto chamber slides for 1 h at room 
temperature.  Initial fluorescence intensity was measured to quantify the number 
of adherent cells prior to the application of force.  After filling the wells with media 
and sealing with transparent adhesive tape, substrates were spun at a fixed 
speed in a centrifuge (Beckman Allegra 6, GH 3.8 rotor) to apply a centrifugal 
force corresponding to 46g.  After centrifugation, media was exchanged and 
fluorescence intensity was read to measure remaining adherent cells.  For each 
well, adherent cell fraction was calculated as the ratio of post-spin to pre-spin 





Statistical Analysis.   
Results were analyzed by ANOVA using SYSTAT 8.0 (SPSS, Chicago, IL).  
If treatments were determined to be significant, pair-wise comparisons were 
performed using Tukey post-hoc test.  A 95% confidence level was considered 
significant. 
 
RESULTS AND DISCUSSION 
Surface Characterization.   
Mixed CH3/EG3-terminated SAMs were assembled by varying the ratio of 
the two alkanethiols in solution but keeping a constant total thiol solution 
concentration.  Ambient air-water-surface contact angles decreased with 
increasing EG3-thiol concentration (Figure 3.1) and values are consistent with 
published results.24,31   EG3 mole fractions in the monolayer (χEG3) were lower 
than the corresponding solution EG3 mole fraction (Figure 3.1) indicating that the 
CH3-terminated thiol assembled preferentially.  The observed surface-solution 
EG3 mole fraction relationship agrees well with other reports of coadsorption of 
alkanethiols.31,33  This empirical relationship was then used to adjust the solution 
concentrations of the two thiols in order to assemble monolayers with surface 
mole fractions ranging from 0 to 1.0 at 0.1 increments. 
 
FN Adsorption to Mixed SAMs. 
FN was selected as the protein model for our study because of its critical 
importance in mediating cell adhesion to surfaces and widespread use in 
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FIGURE 3.1  Characterization of mixed SAMs of CH3/EG3-terminated 
alkanethiols by contact angle ( , left axis) and XPS ( , right axis).  Monolayers 
were assembled by immersion in 2 mM ethanolic solutions containing mixtures 
of the two alkanethiols for 10 h.  Ambient air-water-surface advancing contact 
angle measurements represent mean (3-4 drops) + standard error.  Surface 
mole fractions determined by XPS are reported values determined from the ratio 
of the intensity of O1s peak for the sample divided by the O1s peak intensity for 
pure EG3 monolayer. 
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biomedical and biotechnological applications, including SAM micropatterning.  
FN adsorption onto SAMs was quantified as a function of coating concentration 
using radiolabeled FN.  We have previously demonstrated that this technique 
provides direct measurements of protein adsorption with high sensitivity (0.01 
ng/cm2).29,30  Figure 3.2a shows adsorption profiles for different SAMs exhibiting 
a linear adsorption regime at low coating concentrations and approaching a 
saturation plateau at higher concentrations, as expected for single component 
adsorption.6  Our adsorption measurements for CH3-SAMs and glass (control, 
not shown) are in excellent agreement with previous studies.30,32  Figure 3.2b 
shows adsorbed FN density as a function of EG3 surface mole fraction for 
different FN coating concentrations.  For all EG3 mole fractions, FN adsorption 
increased with increasing coating concentration (p < 0.000003).  For a given 
coating concentration, FN adsorption exhibited sigmoidal decreases with 
increasing EG3 surface composition (p < 0.0007) with a sharp drop-off around 0.5 
EG3 mole fraction.  This trend in adsorption is qualitatively similar to that 
observed with ellipsometry and SPR.24,35  However, at high FN coating 
concentrations, significant amounts of FN adsorbed to the higher EG3 
composition SAMs, including the pure EG3 SAM (Figure 3.2b).  This result 
contradicts previous reports documenting the ability of EG3 moieties to prevent 
protein adsorption.11,24,26  While this behavior may be unique to FN, we attribute 
this observation to the enhanced sensitivity of our measurement method.  It is 
important to note that adsorption studies with SPR have reported detection of a 
layer of surface-associated protein which is quickly (in a manner of seconds) 
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FIGURE 3.2  (a) FN adsorption onto SAMs as a function of FN coating 
concentration showing characteristic adsorption isotherms and differences 
among EG3 surface composition; χEG3   = 0.0,  = 0.5,  = 1.0. (b) FN 
adsorption to mixed SAMs as a function of surface composition (χEG3) showing 
sigmoidal decreases with EG3 surface mole fraction (two separate runs in 
duplicate, mean + standard error); FN coating concentration  = 20 µg/mL,  = 
10 µg/mL,  = 5 µg/mL,   = 1 µg/mL. 
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lost upon removal of the protein coating solution.23,26  This “loosely” associated 
protein layer is not responsible for the FN adsorption observed in this study as 
the SAMs are incubated in BSA solutions for 1 h after FN coating.  In addition, 
we have observed no differences in FN adsorption when the samples are rinsed 
in PBS after FN coating. 
 
Cell Adhesion to FN-Coated SAMs. 
Our adsorption measurements revealed significant FN adsorption onto 
CH3/EG3 mixed SAMs, including pure EG3 monolayers.  In order to determine 
whether the amounts of adsorbed FN were sufficient to mediate specific cellular 
responses, we quantified cell adhesion at 1 h to mixed SAMs as a function of FN 
density using a centrifugation assay.  We previously demonstrated that this 
assay applies controlled and reproducible detachment forces to adherent cells 
and provides relative measurements of adhesion strength.32,34  For a constant 
centrifugal force, the fraction of adherent cells increases sigmoidally with 
adsorbed FN density (Figure 3.3).  Left-right shifts in the adhesion profile 
(adherent cell fraction vs. adsorbed FN density) reflect differences in adhesion 
strength with a left-ward shift indicating higher adhesion at lower FN densities 
and corresponding to higher adhesion strength.  For all EG3 mole fractions, 
adherent cell fraction increased with adsorbed FN density (p < 0.001), 
demonstrating that the adsorbed FN is present at levels sufficient to mediate cell 
adhesion (Figure 3.3).  Interestingly, increasing the EG3 surface composition 
increased the efficiency of the adsorbed FN to support cell adhesion as indicated 
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FIGURE 3.3  NIH cell adhesion to FN-coated SAMs depends on EG3 surface 
composition.  Adhesion profile shows adherent cell fraction as a function of 
adsorbed FN density and sigmoidal curve fits.  Shifts in adhesion profiles 
demonstrate differences in cell adhesion strength with χEG3 (three separate runs 
in duplicate, mean + standard error), χEG3  = 0.0,  = 0.4,  = 0.5,  = 1.0. 
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by left-ward shifts in the adhesion profiles.  We attribute this increased efficiency 
to substrate-dependent differences in the structure of adsorbed FN.  Consistent 
with previous work,10,13,35-37 we have recently demonstrated, using alkanethiol 
SAMs presenting different functional tail groups, that surface chemistry alters FN 
structure and modulates cell adhesion to adsorbed FN.32  In particular, the 
hydrophobic CH3 group exhibited signficant loses in FN adhesion activity while 
the hydrophilic OH moieity supported enhanced cell adhesion.  The present 
findings for the CH3-SAM and the neutral hydrophilic EG3 group are in excellent 
agreement with these observations. 
The results that FN adsorbs onto EG3 SAMs and supports cell adhesion 
indicate that this functional group is not as protein-resistant as previously thought.  
This finding is consistent with the observations of Leckband and co-workers26 but 
appears to conflict with several studies demonstrating that cells do not adhere to 
EG3-functionalized surfaces in the presence of serum-containing 
solutions.21,27,38,39  Leckband et al. noted that cells adhering to EG3-terminated 
SAMs in the presence of serum-containing solutions could be detached by 
incubating in serum-free solutions.  These investigators postulated that the 
adsorbed serum proteins mediating cell adhesion were removed from the surface 
in the absence of serum proteins. 
 
Elution of Adsorbed FN from Mixed SAMs. 
To establish whether adsorbed FN is removed from EG3 SAMs in serum-
free solutions, we measured retention of adsorbed FN on SAMs after incubation 
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in either protein-free (PBS) or serum-containing (10% NCS) solutions for 1 h and 
16 h.  As shown in Figure 3.4, the ability to remove adsorbed FN is dependent 
on the surface and the presence of serum proteins.  For the CH3-terminated SAM 
(χEG3 = 0), there were no differences in adsorbed FN among control and 
incubation treatments (p < 0.27), indicating no removal or displacement of 
adsorbed FN after incubation for up to 16 h in either protein-free or serum-
containing solutions.  This result is consistent with previous studies 
demonstrating irreversible adsorption of FN onto hydrophobic surfaces.10,40  For 
monolayers with 50% EG3, slightly lower densities of FN were measured after 
incubation for 16 h in both protein-free and serum-containing solutions but these 
were not statistically significant from the control (no incubation) group.  In 
constrast, incubation of FN-coated pure EG3 SAM in either protein-free or serum-
containing solutions resulted in significant removal of pre-adsorbed FN (p < 
0.00002).  Long-term (16 h) incubation in PBS was particularly effective in 
removing adsorbed FN down to undetectable levels.  Interestingly, removal of 
adsorbed FN from EG3 surfaces behaved differently from FN removal from glass 
(Figure 3.4).  Incubation in either protein-free or serum-containing solutions 
removed adsorbed FN from glass, but the serum-containing solution was 
significantly more effective at removing FN at longer time points.  This result is 
consistent with a model in which serum proteins displace adsorbed FN on glass.6  
On the other hand, incubating in PBS was more effective than 10% serum in 
removing FN adsorbed on the EG3 monolayer (p < 0.002), suggesting elution of 
the adsorbed FN by concentration gradients rather than displacement by other   
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FIGURE 3.4  Retention of adsorbed FN to CH3/EG3 mixed SAMs after incubation 
in protein-free (PBS) and serum-containing (10% NCS) solutions demonstrating 
surface composition- and solution-dependent elution of adsorbed FN.  SAMs 
were coated with 125I-FN (20 µg/mL), blocked with BSA, and retained 
radioactivity was measured after various elution treatments; no incubation control 
( ), incubation in PBS for 1 h ( ) or 16 h ( ), incubation in 10% NCS for 1 
h ( ) or 16 h ( ).  χEG3 = 1.0, ANOVA p < 0.00002, * control > PBS 1 h (p < 
0.02), † control > PBS 16 h (p < 0.00002), ** control > 10% NCS 16 h (p < 0.02); 
glass, ANOVA p < 0.0001, ‡ control > PBS 1 h, PBS 16 h, 10% NCS 1 h (p < 
0.01), % control > 10% NCS 16 h (p < 0.00002). 
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proteins.  Nonetheless, the exact mechanism(s) for the removal of adsorbed FN 
from these surfaces remains to be elucidated. 
 
Cell Adhesion to FN-Eluted Mixed SAMs. 
We next compared cell adhesion (1 h) to FN-coated SAMs that were 
either pre-incubated in PBS or 10% serum for 16 h or used immediately after FN 
and BSA coating.  Consistent with the FN measurements, there were no 
differences in cell adhesion to CH3-terminated SAMs (Figure 3.5).  Incubation in 
10% serum reduced cell adhesion to the 50% EG3 monolayer (p < 0.05), while 
incubation in PBS had no effect on cell adhesion.  For the pure EG3 monolayer, 
incubation in either PBS or 10% serum reduced adhesion values to background 
levels, whereas control surfaces (no incubation in PBS or 10% serum) again 
supported cell adhesion (p < 0.02) (Figure 3.5).  Furthermore, there were no 
differences in cell adhesion between EG3 monolayers incubated in PBS and 10% 
serum, indicating that once FN is eluted the surface remains non-adhesive even 
in the presence of serum-containing solutions.   A possible explanation for this 
non-adhesive behavior is the adsorption of inert serum proteins that compete out 
adsorption sites on the surface.  This phenomenon also explains our unpublished 
observations that cells adhering to FN-coated EG3 monolayers adhere and 
spread but eventually detach after 6-12 h in culture.  These results reconcile 
observations of FN adsorption and cell adhesion to EG3-functionalized surfaces 
with the body of literature documenting the protein-resistant and non-adhesive 



















FIGURE 3.5  Effects of pre-incubation in protein-free (PBS) and serum-containing 
(10% NCS) solutions on cell adhesion to FN-coated SAMs showing surface 
composition-dependent differences.  Cells were seeded on FN-coated SAMs that 
were either pre-incubated in PBS or 10% serum for 16 h or used immediately 
after FN coating (20 µg/mL); no incubation ( ), incubated in PBS for 16 h ( ), 
incubated in 10% NCS for 16 h ( ).  χEG3 = 0.5, ANOVA p < 0.05, * control, 
PBS > 10% NCS (p < 0.05); χEG3 = 1.0, ANOVA p < 0.02, † control > PBS (p < 





 Effects of Monolayer Assembly Time on FN Adsorption. 
Lastly, we examined the effects of EG3 monolayer assembly time on FN 
adsorption to rule out that our results for FN adsorption and cell adhesion were 
due to longer assembly times (4 h) compared to other studies (typically 1-2 h).  
Although EG3 monolayers assemble within 1 h,41 Mrksich et al. recommended 
using assembly times of less than 12 h for micropatterning applications as they 
observed protein adsorption on EG3 monolayers assembled for longer time 
periods.21  Monolayers assembled for 1, 4, and 16 h were coated with 125I-FN (20 
µg/mL), blocked with BSA, and retained radioactivity was measured immediately 
or after incubation in PBS for 16 h (Figure 3.6).  Significant amounts of FN 
adsorbed onto EG3 SAMs (p < 0.0003) and monolayer assembly time had no 
effect on FN adsorption (p < 0.6).  For all assembly times, incubation in PBS for 
16 h reduced FN adsorption close to background levels. 
 
CONCLUSIONS 
Using highly sensitive protein adsorption and cell adhesion assays, we 
demonstrate significant FN adsorption and cell adhesion to CH3/EG3 mixed SAMs, 
including pure EG3 monolayers.   While FN adsorbed irreversibly to CH3-
terminated surfaces, adsorbed FN was removed from EG3 monolayers and the 
corresponding cell adhesion eliminated by long-term (16 h) incubation in protein-
free or serum-containing solutions.  Once the adsorbed FN was eluted, EG3 
monolayers remained non-adhesive, even in the presence of serum-containing  
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FIGURE 3.6  Effects of monolayer assembly time on retention of adsorbed FN for 
pure EG3 SAMs.  Monolayers were coated with 125I-FN (20 µg/mL), blocked with 
BSA, and retained radioactivity was measured immediately ( ) or after 
incubation in PBS for 16 h ( ).  Adsorbed FN measurements revealed no 
dependence on SAM assembly time. 
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media.  These results provide new insights into the interactions between cells 
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SURFACES THAT DIRECT ASSEMBLY OF FIBRILLAR  
EXTRACELLULAR MATRICES  
 
SUMMARY 
 Biomimetic engineering focuses on integrating recognition/structural 
motifs from biological macromolecules with synthetic or natural substrates to 
generate biofunctional materials. However, current biomimetic approaches do not 
reconstitute spatial or temporal organization associated with natural extracellular 
matrices (ECMs).  In the present study, we engineered model surfaces that 
promote cell-mediated assembly of robust ECMs.  By tethering a short peptide 
from the self-assembly domain of the ECM protein fibronectin (FN) onto non-
fouling supports, we generated surfaces which promote cell-mediated assembly 
of robust FN matrices compared to control and bioadhesive RGD-functionalized 
supports.  Furthermore, these ECM-mimetic surfaces direct the co-assembly of 
type I collagen (COL) fibrils within the FN architecture, and increases the 
proliferation rates of adherent cells nearly two-fold compared to conventional 
supports.  Given the critical roles of fibrillar matrices on cell migration, 
proliferation, and differentiation, this approach provides a promising strategy for 







Biologically-inspired materials have emerged as promising substrates for 
enhanced repair in various therapeutic and regenerative medicine applications, 
including nervous and vascular tissues, bone, and cartilage.1-4  The extracellular 
matrix (ECM) plays a central role in tissue morphogenesis, homeostasis, and 
repair,5 and characteristics of the ECM are therefore worthy of mimicking to 
provide control of cellular activities on synthetic substrates.  The ECM is a 
dynamic-insoluble network of proteins and polysaccharides secreted and 
assembled locally by cells.6  Cells are constantly remodeling the ECM to maintain 
the structure and presentation of protein ligands and growth factors.  The 
complex organization of matrix-assembled proteins provides structural support to 
cells within tissues while also providing signaling cues vital for cellular regulation, 
development, migration, proliferation, shape and function.6-12   
Biomimetic materials incorporating recognition and structural motifs from 
biological macromolecules provide innovative targets for the engineering of 
substrates with tailored biofunctionality and novel properties.1,13  These strategies 
primarily focus on the development of materials which incorporate well-
characterized domains from biomacromolecules to mimic individual functions of 
the ECM, including cell adhesive motifs,13,14 growth factor binding sites,15 and 
protease sensitivity.16 While current biomimetic materials imitate selected ECM 
attributes, they exhibit reduced activity compared to natural matrices and often 
do not encompass the full spectrum of functions necessary for robust control of 
cell activities associated with natural ECMs.17   
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These current materials displaying ECM characteristics also fail to 
reconstitute the vital fibrillar supramolecular structure of the natural ECM.  The 
fibrillar structure of fibronectin (FN) matrices modulates cell cycle progression, 
migration, gene expression, cell differentiation, and the assembly of other matrix 
proteins.5,7,10,18  However, recent efforts have focused on mimicking the fibrillar 
nature of native ECM by electrospinning of proteins19 and synthetic polymers20 
into nanofibers.  Stupp and coworkers have made advancements in self-
assembly of amphiphilic nanofibers which incorporate biomolecules,21 while 
McLeod and colleagues have developed sulfonated polystyrene surfaces which 
mediate FN fibrillogenesis.22  Ma and coworkers have developed nano-fibrous 
polymer scaffold that enhance serum protein adsorption leading to increased cell 
attachment.23  Even though these methods produce fibrillar scaffolds, there is 
little control over the spatial or temporal distribution of bioactive domains, or the 
non-specific adsorption of serum proteins.  Current biomaterials do not actively 
promote cellular deposition and assembly of ECM. In the present study, we 
describe biomimetic surfaces that direct cell-mediated co-assembly of robust 
fibrillar FN and type I COL matrices through the use of an oligopeptide sequence 
(FN13) from the self-assembly domain of FN which enhances matrix assembly 
when added in soluble form.24  Furthermore, tethering of this oligopeptide to non-
fouling substrates significantly enhanced cell-mediated ECM assembly.  Cells 
cultured on FN13-functionalized surfaces also exhibit increases in proliferation 
rates.  Given the critical roles of fibrillar matrices on regulating numerous cell 
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MC3T3-E1 osteoblast-like cells were obtained from the RIKEN Cell Bank 
(Tokyo, Japan).  Cells were maintained in α-Modified Eagle’s Medium 
supplemented with 10% fetal bovine serum (FBS, HyClone, Logan, UT), penicillin 
(100 units/mL), and streptomycin (100 mg/mL).  Cell culture reagents, including 
human plasma FN and Dulbecco’s phosphate buffered saline (DPBS) were 
purchased from Invitrogen (Carlsband, CA).  Tri(ethylene glycol)-terminated 
alkanethiol (HS-(CH2)11-(EG)3OH, EG3)25 was synthesized as previously 
described (previous chapter) and characterized by 1H and 13C NMR, FTIR, and 
mass spectrometry.  All starting materials for synthesis, cell culture and chemical 
reagents as well as rabbit anti-FITC alkaline phosphatase-conjugated antibodies 
were used as received from Sigma Aldrich (St. Louis, MO).  Texas Red®-
conjugated goat anti-rabbit IgG, ethidium homodimer-2, AlexaFluor488-
conjugated anti-mouse IgG, and Hoechst dye were purchased from Molecular 
Probes (Eugene, OR).  Mouse anti-BrdU antibody was purchased from Becton 






Synthesis of HS-(CH2)11-EG6-OCH2-COOH 
Carboxylic acid functionalized hexa(ethylene glycol)-terminated 
alkanethiol (HS-(CH2)11-(EG)6-OCH2-COOH) was synthesized (Scheme 4.1) as 
previously described26 and characterized by 1H- and 13C-NMR, Fourier 
transformed infrared spectroscopy, and mass spectrometry. 
Undec-1-en-11-ylhexaethlene glycol (4)   
A mixture of hexa(ethylene glycol) (234.7 mmol) and 3.75 ml of 50% 
NaOH was refluxed for 0.5 h at 100 oC under an atmosphere of nitrogen and  11- 
bromoundec-1-ene (10.40 ml, 47.4 mmol) was added.  The mixture was refluxed 
for 24 h, cooled and extracted with hexane (6 x 50 ml).  The hexane extracts 
were combined and the solvent was evaporated under reduced pressure to 
afford a yellow oil.  The oil was purified using chromatography (silica gel; gel 1 of 
ethyl acetate, followed by gel 2 of 19:1 CHCl3/MeOH) to give of monoether (75%, 
4):  1H NMR (300 MHz, CDCl3) δ1.25 (br m, 12 H, alkane), 1.55 (qui, 2H, J = 7 Hz, 
C-10), 1.7 (br s, 1H, C-OH), 2.05 (q, 2H, J = 7 Hz, C-3), 3.45 (t, 2H, J = 7 Hz, C-
11), 3.55-3.75 (m, 24H, OCH2CH2O), 4.90-5.05 (qq, 2H, J = 6.7, 3.4, 1.65, C-1), 
5.75 (qt, 1H, J = 6.7, 3.4, C-2);  13C NMR (75 MHz, CDCl3) δ139.13, 114.02, 
72.45, 71.43, 70.46, 70.20, 69.27, 61.58, 33.69, 29.51, 29.43, 29.37, 28.82, 
25.97; MS (CI, ammonia), M+1 435.2, M+18 454.3;   IR (neat, cm-1) vmax 3468.43 







































SCHEME 4.1. Conditions; a) Hexa(ethylene glycol), 50% NaOH, 100 oC, 0.5 h; 
11-bromoundec-1-ene, 100 oC, N2, 24 h. b) Ethyl diazoacetate, BF3.Et2O, dry 
CH2Cl2,    0 oC 0.5 h, 2 h r.t.  c) AIBN, Thiolacetic acid, dry THF, over night, N2, 
hv. d) 0.8 M HCl in CH2Cl2, r.t. 16 h, N2. 
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Undec-1-en-11-yl hexa(ethylene glycol) ethyl ester  (5)   
All starting materials were cooled to 0 oC before combined.  4 (10.06 g, 
23.18 mmol), ethyl diazoacetate (3.28 mL, 25.92 mmol), and BF3.Et2O (0.23 ml, 
2.31 mmol) were dissolved in 50 ml of dry CH2Cl2.  The reaction mixture was 
stirred at 0 oC for 0.5 h, then allowed to warm to room temperature for 2 h.  
Saturated aqueous ammonium chloride (25 ml) was added and the reaction was 
placed into a separatory funnel.  The organic phase was collected and the 
aqueous phase was washed with CH2Cl2 (5 X 20 ml).  The combined organic 
phases were dried with magnesium sulfate and the solvent was removed to give 
a yellow oil.  Flash column chromatography (eluant: 1:1 ethyl acetate/hexanes  
methanol) gave 5 a clear oil  (30%); 1H NMR (300 MHz, CDCl3) δ 1.25-1.35 (br s, 
16 H, alkane, C-27), 1.55-1.60 (qui, 2 H, J = 6.6, 6.9 Hz, C-10), 2.0-2.09 (dd, 2 H, 
J = 6.9 Hz, C-3), 3.43-3.48 (t, 2 H, J = 6.6 Hz, C-11), 3.55-3.75 (m, 24 H, 
OCH2CH2O), 4.15 (s, 2 H, C-24), 4.18-4.25 (q, 2 H, J = 7.2 Hz, C-26), 4.9-5.05 
(qq, 2 H, J = 3.3, 6.6 Hz, C-1), 5.75-5.85 (qt, 1 H, J = 3.3, 6.6, C-2); 13C NMR (75 
MHz, CDCl3) δ 170.426, 139.188, 114.067, 71.490, 70.837, 70.534, 70.003, 
68.682, 60.743, 33.755, 29.581, 29.475, 29.414, 29.065, 28.868, 26.029, 14.144;  
MS (EI, molecule shows self CI) M+1 521.36886;   IR (neat, cm-1) vmax 3080.0 
(CH sp2), 2926.17 (CH asymmetric sp3), 2857.49 (CH2 symmetric), 1754.58 





[1-[(Methylcarbonyl)thio]undec-11-yl]-hexa(ethylene glycol)  ethyl ester  (6)   
Compound 5 (4.0 mmol) was added to a solution of thiolacetic acid (16.0 
mmol) and  AIBN (1 mmol) in dry THF (20 ml) and the mixture was irradiated 
overnight under an atmosphere of nitrogen with a 450-W medium pressure 
mercury submersion lamp.  The solvent was evaporated under reduced pressure, 
and the crude product (6) was purified with flash column chromatography (eluant: 
30:1 CH2Cl2/MeOH) to yield a yellow oil (80%); 1H NMR (300 MHz, CDCl3) δ 1.25 
(m, 17H, alkanes), 1.52 (m, 4H, C-9, C-10), 2.32 (s, 3H, -CH3), 2.85 (t, J = 7.2, 
2H, S-CH2), 3.44 (t, J = 6.9, 2H, O-CH2, C11), 3.56-3.74 (m, 24H, OCH2CH2O), 
4.15 (s, 2H, OCH2C=O), 4.22 (q, J = 7.2, 2H, OCH2CH3): 13C NMR (75 MHz, 
CDCl3) δ 14.18, 26.03, 28.76, 29.05, 29.42, 29.57, 60.76, 68.65, 69.99, 70.52, 
70.82, 71.49, 170.44, 195.96; FAB M+1 597.3672;  IR (neat, cm-1) v max 3323.32, 
2926.14 (CH2 asymmetric stretch), 2856.99 (CH2 symmetric stretch), 2368.74 (S-
C), 2340.53 (S-C), 1754.19 (C=O), 1121.34 (C-O). 
 
11-[19-Carboxymethylhexa(ethylene glycol)]undec-1-yl-thiol (7) 
Thioacetate 6 was dissolved in 0.8 M HCl in CH2Cl, and the mixture was 
stirred at room temperature for 16 h under nitrogen.  Solvent was removed and 
the crude product was purified using chromatography (silica gel; 88:5:5:2 
CHCl3/MeOH/Hexanes/AcOH, if needed) 86% yield; 1H NMR (300 MHz, CDCl3) 
δ 1.3 ( br s, 18 H, alkane), 1.67 (t, 1 H, J= 7 Hz, C-SH), 2.5 (dt, 2 H, CH2-S),  3.4 
(t, 2 H, J = 7, C-11), 3.5-3.75 (m, 24 H, OCH2CH2O), 4.1 (br s, 1 H, C-OH); 13C 
NMR (75 MHz, CDCl3) δ 24.52, 26.62, 28.73, 28.80, 29.06, 29.56, 29.80, 29.91, 
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29,97, 30.03, 30.79, 30.24, 30.33, 34.56, 70.92, 171.50;  MS (EI) M+1 527.4,  IR 
(neat, cm-1) v max 3498.34 (-OH, COOH stretch), 2925.45 (CH2 asymmetric 
stretch), 2855.92 (CH2 symmetric stretch), 1754.2 (C=O), 1461.72 (CH2 
scissoring), 1350.13 (CH2 wagging), 1247.64 (CH2 twisting), 1116.11 (C-O 
stretch), 732.75 (CH2 rocking). 
 
SAM Assembly.   
Glass cover slips and chamber slides were cleaned by O2 etching for 3 
min in a plasma etcher (Plasmatic Systems, Inc., North Brunswick, NJ).  
Substrates were sequentially coated with 100 Å Ti and 150 Å Au (2.0 X 10-6 torr, 
2.0 Å/sec) using a Thermionics VE-100 electron beam evaporator (Modesto, CA).   
Mixed SAMs were prepared by immersing Au substrates in a 1 mM solution (total 
thiol concentration) containing a 19:1 ratio of EG3 and EG6-COOH for 4 or 16 h.  
The composition of monolayers was assumed to be the same as the ratio in 
solution.27  SAMs containing carboxylic acids were incubated for 30 min in 2 mM 
EDC (1-ethyl-3-(3-dimethyl-aminopropyl)carbodiimide hydrochloride) and 5 mM 
NHS (N-hydroxysuccinimide) in 0.1 M 2-(N-morpholino)-ethanesulfonic acid and 
0.5 M NaCl, pH 6.0, and then immersed in a  20 mM solution of 2-
mercaptoethanol in deionized water for 5 min.   FN13 peptide (synthesized by the 
BioScience Center, Georgia Institute of Technology, Atlanta, GA), scrFN13 
(synthesized by the Emory University Microchemical Facility, Atlanta, GA), or 
RGD peptide (GRGDSPC, BACHEM, San Diego, CA) was then tethered to 
activated SAMs (FN13 & scrFN13 = 23 µM (40 µg/ml) , RGD = 72 µM (50 µg/ml), 
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unless noted).   Unreacted active NHS esters were quenched in 20 mM glycine 
for 10 min, followed by treatment with 1% heat-denatured bovine serum albumin 
(BSA) for 30 min.  Peptide tethering steps were monitored by PIERS for 
signature infrared carbonyl peaks.  Detection was performed using a Nexus 470 
FT-IR spectrometer with a SMART SAGA accessory and a DTGS KBr detector 
(Thermo Nicolet, Madison, WI).  Spectra were obtained from 1024 scans at 2 cm-
1 resolution and reported as relative intensities measured in absorbance.  Peak 
assignments were based on Frey and Corn.28  
 
Quantification of Surface Peptide Density.   
ENZYME LINKED IMMUNOSORBENT ASSAY (ELISA) 
Peptides were biotinylated at the cysteine residue to quantify immobilized 
density.  Each peptide was reconstituted at 1 mg/ml in 100 mM sodium 
phosphate and 5 mM EDTA, pH 6.0.  EZ-LinkTM PEO-maleimide activated biotin 
(10 mM) was added to the peptide solution and incubated in the dark at room 
temperature for 16 h.  After blocking in 1% BSA, SAMs were incubated in 
alkaline phosphatase-conjugated anti-biotin antibodies in 5% FBS blocking buffer 
for 1h at 37 oC.  After rinsing, substrates were incubated in 5-methylumbelliferyl 
phosphate (100 µM) for 1h at 37 oC.  Reaction supernatants were transferred to 
black 96-well plates and the resulting fluorescence (360 nm excitation/ 465 nm 
emission) was recorded using a HTS 7000 Plus BioAssay microwell plate reader 
(Perkin Elmer, Norwalk, CT). Relative fluorescence intensity, which is 
proportional to the amount of peptide tethered, was determined as a function of 
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peptide coating concentration.  Control immobilization experiments at various 
ratios of labeled and unlabeled peptide demonstrated no adverse effects of 
biotinylation on peptide tethering. 
 
ELLIPSOMETRY 
SAM surface thickness was characterized using null ellipsometry at λ = 
6328 Å, and a 75o angle of incidence (Sopra GES 5).  Ellipsometry readings 
were taken on the SAM coated gold cover slips prior to peptide tethering to 
establish the bulk optical constants, and after peptide immobilization to calculate 
the thickness of the peptide layer using a three-phase ambient / film / SAM 
substrate model (Winell: Version 4.07 Sopra, Inc. Westford, MA) in which the film 
was assumed to be isotropic and assigned a scalar refractive index value of 1.40.  
Elliptical constants used were confirmed experimentally with those previously 
reported.27,29  Four separate points were measured on each sample and the 
readings were averaged.  Film thickness was converted to absolute peptide 
density using the de Feijter’s formula.30 
 
FN Matrix Assembly.   
FN matrix assembly was visualized by immunofluorescence staining.  
SAMs functionalized with saturating levels of peptides (~35 pmol/cm2) were 
seeded with MC3T3-E1 cells (200 cells/mm2) in culture media.  After 48 h, the 
media was aspirated and substrates were rinsed twice with DPBS.  Samples 
were fixed with 3.6% formaldehyde for 10 min, rinsed and blocked in 1% BSA for 
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10 min.  Samples were then incubated in rabbit polyclonal antibody against FN, 
followed by Texas Red®-conjugated goat anti-rabbit IgG and Hoechst. Digital 
images at equal exposures were obtained and analyzed for FN staining area.  FN 
quantification was normalized by cell number and reported as FN matrix/ cell on 
images taken with a 100 X objective.  
 
Biochemical Analysis of Assembled  FN Matrix.   
Isolation and detection of DOC–insoluble material was performed as 
described by Sechler et al.31  After 48 h in culture, cells were rinsed with DPBS 
and lysed in deoxycholate (DOC) lysis buffer (2% DOC, 0.02 M Tris-HCl, pH 8.8, 
2 mM phenylmethylsulfonylfluoride, 2 mM EDTA, 2 mM iodoacetic acid, and 2 
mM N-ethylmaleimide).  DOC-insoluble fraction was isolated by centrifugation 
and solubilized in 1% SDS, 25 mM Tris-HCl (pH 8.0), 2 mM 
phenylmethylsulfonylfluoride, 2 mM EDTA, 2 mM iodoacetic acid, and 2 mM N-
ethylmaleimide.  After normalizing by cell number, samples were separated by 
electrophoresis on 5% polyacrylamide gels under reducing conditions.  Following 
transfer to nitrocellulose membranes, immunodetection was performed with 
rabbit polyclonal antibodies against FN followed by anti-rabbit alkaline 
phosphatase conjugated antibody (or with anti-FITC alkaline phosphatase 
conjugated antibody to detect FITC labeled FN).  Nitrocellulose membranes were 
then incubated in ECF substrate, imaged on a Fuji FLA-3000 phosphoimager, 
and quantified by image analysis. 
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FN was fluorescently labeled with FITC-maleimide (Pierce Biotechnology) 
at the cysteine residue to quantify soluble FN incorporation within the assembled 
matrix.  FN was reconstituted at 1 mg/ml in 100 mM sodium phosphate and 5 
mM EDTA, pH 6.0.  FITC-maleimide (10 mM in DMSO) was added to the FN 
solution, and incubated in the dark at room temperature (16 h).  Unreacted FITC 
was removed by centrifugation with a 30 kDa filter (Micon Bioseparations).  Final 
concentration of FITC-FN were determined using optical constants.  FITC-FN 
was supplemented  in FN-depleted serum (20 nM), and used to culture cells. 
  
Collagen Fibril Assembly.   
Following 24 h of culture, media was replaced with equal volumes of fresh 
culture media (37 oC) and culture media supplemented with FITC-labeled type I 
collagen (25 oC, Chondrex, Inc., Redmond, WA) to give a final concentration of 1 
µg/ml.  Following additional 24 h incubation with FITC-collagen, substrates were 
fixed and stained for FN as described above. 
 
Cell Proliferation.   
MC3T3-E1 cells were synchronized by culturing under serum-free 
conditions (α-MEM + 0.1% albumin) for 3 days.  Cells were then seeded at a low 
density (50 cells/mm2) to ensure logarithmic growth in αMEM supplemented with 
10% FBS onto ligand-functionalized substrates.  After 24 h in culture, cells were 
pulsed for 4 h with BrdU (10 mg/ml final concentration).  Substrates were then 
washed with DPBS, fixed with 95% ethanol for 10 min, and denatured in HCl for 
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20 min.  Following neutralization in 50 mM NaCl (in 100 mM Tris-HCl, pH 7.4) 
and blocking in 5 % FBS + 1 % BSA, cultures were sequentially incubated in 
mouse anti-BrdU antibody (25 ng/ml) and Alexa-Fluor488-conjugated anti-mouse 
IgG (10 µg/ml).  Cell nuclei were counter-stained with ethidium homo-dimer 2 (1 
µM).  Substrates were then scored by fluorescence microscopy for proliferation 
as the percentage of cells positive for BrdU incorporation relative to the total 
number of cell nuclei.  At least twenty representative images were analyzed per 
sample. 
 
Micropatterned Surfaces.   
Microcontact printing was used to pattern self-assembled monolayers 
(SAMs) of alkanethiols on Au into adhesive and nonadhesive domains.32  Using 
standard photolithograpy methods, we manufactured master templates of 
microarrays of linear patterns (10 µm wide with 50 µm line-line spacing), on Si 
wafers as previously described.33  Briefly, photoresist (5 µm thick) was spun onto 
a Si wafer and exposed to UV light through an optical mask containing the 
desired pattern to degrade the photoresist. The exposed areas were then etched 
away, leaving a template mold of recessed wells (5 µm deep) with the desired 
patterns. The template was exposed to (tridecafluoro-1,1,2,2-tetrahydrooctyl)-1-
trichlorosilane under vacuum to prevent adhesion of the elastomer to the 
exposed Si.  The PDMS precursors (Sylgard 184/186, 10:1) and curing agents 
were mixed (10:1), poured over the template in a dish (forming an approximately 
10-mm-thick layer), evacuated under vacuum to remove air bubbles from the 
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elastomer, and cured at 65 °C for 12 h. The cured PDMS stamp containing the 
desired array of circular posts was then peeled from the template.   
Stamps were cleaned by sonicating in 50% EtOH for 15 min and the flat 
back of the stamp was allowed to self-seal to a glass slide to provide a rigid 
backing. Au-coated cover slips were rinsed with 95% EtOH and dried under a 
stream of N2. The face of the stamp was inked with 1 mM ethanolic solution 19:1 
EG3:EG6-Acid and then quickly blown dry with N2. The stamp was brought into 
conformal contact with the Au-coated substrate for 2 min to produce an array of 
linear islands of the desired thiol mixture.  Subsequently, the cover slips were 
incubated in a 1 mM ethanolic solution of tri(ethylene glycol)-terminated 
alkanethiols for 4 h to create a nonfouling and nonadhesive background around 
the islands. Finally, micropatterned substrates were rinsed in 95% EtOH and 
dried with N2. Micropatterned substrates were treated as above to tether 
saturating densities of FN13 peptide, followed by MC3T3-E1 seeding at 200 
cells/cm2.  After 48 h, cells were fixed and stained to visualize FN matrix. 
 
Statistical Analysis.   
Results were analyzed by analysis of variance using SYSTAT 8.0 (SPSS).  
If treatments were determined to be significant, pair-wise comparisons were 
performed using Fisher’s least-significant-difference test.  A 95% confidence 




RESULTS AND DISCUSSION 
Surface Characterization.   
To create non-fouling substrates that can selectively immobilize ligands 
with controlled densities, we used mixed self-assembled monolayers (SAMs) of 
alkanethiols on Au (19:1 EG3: EG6-COOH, Figure 4.1a). SAMs have been used 
to immobilize biomolecules to inert surfaces for several applications.34-36  This 
surface composition was selected for its ability to resist non-specific protein 
adsorption from solution while retaining the ability to support cell adhesion to 
tethered ligands. The carboxylic acids present in the SAM were converted to N-
hydroxysuccinimide (NHS) esters which underwent reaction with oligopeptides to 
immobilize the ligands by amine groups (Figure 4.1b).27,37,38  The chemical 
conversion of this reaction was monitored step-by-step by polarized infrared 
external reflectance spectrometry (PIERS, Figure 4.1c).  Pure EG3 SAMs display 
no peaks in the carbonyl region of the spectrum, while SAMs consisting of 19:1 
EG3: EG6-COOH show a sharp peak at 1621 cm-1 corresponding to the carbon-
oxygen double bond stretch of the carboxylic acid.  The intensity of this peak was 
reduced after treatment with EDC and NHS, indicating conversion of the acid to 
the NHS ester.  New peaks at 1741 cm-1, 1780  cm-1, and 1819 cm-1 indicate 
asymmetric stretch of the NHS carbonyl bonds, symmetric stretch of the NHS 
carbonyl bonds, and activated ester carbonyl bonds, respectively.  Subsequent 
tethering of peptide ligand is indicated by the appearance of an amide carbonyl 
stretching vibration (1659 cm-1) from both the peptide backbone and the peptide- 
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FIGURE 4.1  Surface composition and characterization of the model non-
fouling surfaces used to create ligand-tethered surfaces.  (a) Structures of 
functionalized alkanethiols used to create nonfouling SAMs with COOH 
groups for ligand tethering.  (b) Scheme for reaction of surface-bound 
carboxylic acids.  (c) PIERS spectra acquired for a pure EG3 SAM, b mixed 
unmodified SAM of 19:1 EG3: EG6-COOH, c a mixed SAM of 19:1 EG3: EG6-
COOH following activation with NHS, and d peptide-tethered surface. 
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 SAM tether.  The peak corresponding to N-H bending at 1547 cm-1 gives further 
indication of peptide immobilization.   
 
Peptide Immobilization. 
Schwarzbauer at colleagues have used recombinant FN molecules to 
identify domains within FN that play a role in FN matrix assembly.39  These 
truncated FN molecules readily incorporate into the FN matrices of numerous cell 
types.  Ruoslahti and coworkers have identified a 14 kDa fragment located 
between the first two type III repeats of FN which specifically binds FN.40  A 31-
amino acid sequence from this peptide retained activity, and is believed to play a 
role in the secondary mechanisms of FN matrix assembly.  More recently, Barlati 
has discovered a 13-amino acid sequence (FN13) from the COL binding domain 
of FN that has been shown to increase FN matrix assembly when added to the 
culture media of several cell types.24  This peptide also promoted the co-
assembly of COL matrices.  Since this 13-amino acid sequence is currently to 
smallest sequence isolated that promotes FN matrix assembly, it represented an 
excellent strategy for surface-induced FN matrix assembly to non-fouling 
supports.   
Three oligopeptides were immobilized using this strategy: FN13 
(KGGGAHEEICTTNEGVM), a control scrambled sequence (scrFN13, 
KGGGITCETNEGEVAMH), and bioadhesive RGD (GRGDSPC).14,35 The FN13 
and scrFN13 peptides were extended with an additional KGGG spacer on the N-
terminus to tether these sequences to the SAM.  Each peptide was biotinylated 
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at the cysteine residue to quantify relative tethered density by ELISA using 
alkaline phosphatase-conjugated anti-biotin antibodies. All of the peptides 
exhibited similar immobilization profiles (Figure 4.2). There was an initial linear 
increase in tethered peptide density upon increasing the concentration of the 
peptide in solution, followed by a saturation plateau at high solution concentration.  
SAM surfaces that were not transformed with NHS esters prior to peptide 
exposure displayed consistently low levels of tethered peptide, regardless of the 
coating concentration.  Together, these results indicate that the amount of 
peptide tethered to the surface can be tightly controlled by varying the coating 
concentration (Figure 4.2).  Aside from only obtaining relative immobilized 
peptide levels, an additional limitation of this technique is that steric interactions 
between antibody molecules could underestimate peptide densities at high 
concentrations. 
To overcome this limitation, ellipsometry was used to obtained absolute 
surface densities of the immobilized peptides by measuring changes in the 
peptide film thickness.  This analytical technique was utilized for its convenient 
(no vacuum or labeling of peptide required) and non-destructive ability to directly 
measure changes in film thickness with precision at low resolution (0.01 nm or 
better).30  By using the de Feijter’s formula, changes in film thickness were 
converted to absolute peptide surface density (Figure 4.3):41 
 
Γ = t(n – n0) 
        dn/dc 
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FIGURE 4.2  FN13 tethering profile by ELISA.  Relative surface density of 
biotinylated-FN13 peptide on both NHS activated ( ), and Unmodified ( ) 
SAMs. 
FN13 Peptide Coating Concentration (µΜ)































FIGURE 4.3  Peptide tethering densities measured by Ellipsometry.  Dotted line 
represents theoretical maximum surface density for complete conversion of 
available binding sites.  (a)  NHS Activated ( ), and Unmodified ( ) SAMs. 
There were no significant differences between activated surfaces exposed to 
peptides, or between unmodified surfaces that were exposed to peptides.  
Significant differences in peptide densities were determined between NHS 
activated and unmodified surfaces exposed to peptides. (p < 0.0002).   (b) 
FN13 immobilization profile.  Curve fit to linear model and used to determine 
densities over full range of coating conditions. y = 1.54x R2 = 0.96. 
a 
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Here, Γ is defined as surface concentration (g/cm2), t is the film thickness (cm), n 
is the refractive index of the peptide (assumed 1.40),30 n0 is the ambient 
refractive index, and dn/dc is the refractive index formula (cm3/g).  Figure 4.3a 
shows the surface density of each peptide obtained for both NHS activated and 
unmodified surface treatments.  The peptide coating solutions used for this 
measurement are the same used in all subsequent experiments, unless noted.  
By varying the coating concentration of FN13 peptide in solution we were able to 
obtain an immobilization profile for the peptide as a function of peptide coating 
concentration (Figure 4.3b).  This data is in excellent agreement with ELISA in 
that a linear relationship between solution concentration and surface density was 
obtained at low densities.  By simply varying the peptide solution concentration, 
we are able to control the surface density of FN13 peptide. 
 
FN Matrix Assembly. 
To investigate the ability of these surfaces to direct FN matrix assembly, 
MC3T3-E1 osteoblast-like cells were seeded on substrates presenting molar 
equivalent peptide densities. Matrix assembly was analyzed after 48 h in culture 
by immunofluorescence staining.  Robust fibrillar FN matrices were assembled 
on surfaces presenting FN13 (Figure 4.4a).  Remarkably, FN13-tethered 
surfaces promoted higher levels of FN matrix assembly than RGD-functionalized 
substrates. Cells do not assemble matrices on the scrFN13 modified surfaces, or 
unmodified (19:1 EG3:EG6-COOH SAM) control surfaces.  The low levels of FN 







FIGURE 4.4  FN matrix assembly on peptide-functionalized surfaces. (a) 
Assembled FN matrix architecture for functionalized surfaces (FN = red, DNA = 
blue, scale bar 10 µm).  (b) Western blot for DOC detergent insoluble FN (250 
kD) under reduced conditions.  (c) Quantification of FN matrix assembly, values 
reported as fold over Unmodified surface. * vs. Unmodified (p < 0.00006).   
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studies illustrating decreased levels of assembled ECM on substrates 
functionalized with increasing densities of RGD containing peptides.42   
During cell-mediated matrix assembly, FN at the surface of the cell is 
cross-linked into high molecular weight multimers through disulfide bond 
formation and assembled into supramolecular structures through cytoskeleton-
induced tension.43,44  Matrix-assembled FN is characterized by deoxycholate 
(DOC)-insoluble fibrils stabilized through disulfide cross-linking.39  Further 
characterization of our FN13 oligopeptide-induced matrix assembly by Western 
blot analyses of DOC-insoluble matrices was in excellent agreement with 
immunostaining observations (Figure 4.4b).  Our results indicated differences in 
FN matrix assembly on ligand-functionalized substrates (FN13 > scrFN13 > RGD 
= Unmodified) as detected via both immunofluorescent staining and isolation of 
DOC detergent-insoluble FN matrix.  FN13-tethered surfaces promoted nearly 
ten-fold higher levels of DOC-insoluble FN matrix compared to RGD-
functionalized substrates and control surfaces presenting no oligopeptides 
(Figure 4.4c).  This data reports the first biomimetic surface that actively 
promotes cell-mediated assembly of FN matrices.1,45 
 
Critical FN13 Surface Density. 
To examine the dependency of cell-mediated FN matrix assembly on the 
surface density of FN13 peptides, we functionalized the surfaces with a range of 
FN13 densities.  Interestingly, we saw no density-dependent response in 
assembled FN matrices over a wide range of FN13 coating concentrations.  
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DOC-insoluble FN matrices were detected in equal amounts on FN13-
functionalized surface that were functionalized with FN13 peptide ranging from 
8.9 fmol/cm2 to saturation at 35 pmol/cm2 (Figure 4.5).  This high level of FN13 
induced FN matrix was followed by a sharp decrease in FN matrix to background 
levels at lower surface densities (6.2 fmol/cm2 and below); indicating that the 
amount of FN13 above a critical density had no effect on the extent of assembled 
FN matrices.    
For a better understanding of the significance of this critical FN13 surface 
density, we calculated the distribution of peptides on the surface.  We determined 
the spacing of FN13 peptides at the critical density to be ~105 nm.  The extended 
length of a FN molecule is between 90-120 nm.  This spacing of peptides 
supports Erickson’s model for FN elasticity described by the extension of FN 
dimmers.46,47  These FN13-functionalized surfaces may provide an additional 
means to studying the controversial mechanism surrounding FN elasticity within 
FN matrices.46,48   
 
 FN Incorporation into Matrices. 
FN matrices are commonly assembled from FN that is either secreted by 
the cell, or from soluble FN within the surrounding environment.18  To investigate 
the source of FN within assembled matrices, MC3T3-E1 cells were seeded on 
FN13-tethered surfaces in FN-depleted media.  The culture media for half of the 
samples were supplemented with FITC-labeled FN (20 nM).  The composition of 
FN matrices was examined via both Western blot analyses of DOC-insoluble FN 
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FIGURE 4.5  Critical FN13 density required to assembly FN matrices. (a)  
Western blot for DOC detergent insoluble FN (250 kD) under reduced 
conditions.  Values represent the surface density of FN13.  (b) Quantification of 
FN matrix assembly, values reported as fold over Unmodified surface (n > 3, +/- 
stder, …. represents values for Unmodified surface).  Curve fit to nonlinear 
regression (R2 = 0.97). (c) Assembled FN matrix architecture for FN13-
functionalized surfaces (FN = red, DNA = blue, scale bar 10 µm). 
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and immunofluorescence staining.  Western blots with anti-FN antibodies, for 
total FN, showed equal amounts of FN assembled with or without addition of 
soluble FN to the culture media (Figure 4.6a).  Furthermore, no FITC-labeled FN 
was detected in DOC-insoluble fractions indicating that soluble FN from media 
was not incorporated into the FN matrices.  The lack of detectable staining for FN 
matrix on FN13-presenting surfaces cultured in the absence of cells determined 
that the matrix assembly on these substrates is entirely cell mediated. 
Interestingly, addition of soluble FN13 (40 µg/mL) to cells on surfaces which lack 
the immobilized ligand did not result in FN matrix assembly (Figure 4.6b).  
Additional evidence of the surface directed FN13-induced FN matrices was 
explored using micropatterning techniques.32,33  By pattering the 19:1 EG3:EG6-
Acid thiol mixture into 10 µm lanes, FN13 peptides were selectively immobilized 
into linear patterns surrounded by a non-adhesive background.  Cells were only 
able to adhere and assemble FN matrices within those domains (Figure 4.7).  
Together, these results highlight the necessity of surface-immobilization of FN13 
to promote the cell-mediated assembly of secreted FN matrices. 
 
Peptide Induced ECM Co-assembly. 
 The FN13 peptide was originally isolated from a 13-amino acid sequence 
of the FNII1-FNI7 domains.24  This region of FN poses the main collagen (COL) 
binding domain in assembled FN matrices.  Native FN matrices display a distinct 
region for binding type I COL molecules, and FN matrices have been shown to 
regulate the deposition of COL.24,49  The bioactivity of these surfaces were 
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FIGURE 4.6  Investigation of FN13-induced FN matrices.  (a)  Western blot for 
DOC detergent insoluble FN for cells cultured in FN-depleted serum either 
without (No FN) or with (FITC-FN) supplemented FITC-labeled FN (20 nM).  
Total FN matrix assembled as detected with either anti-FN antibodies, or anti-
FITC antibodies.  (b)  Effect of soluble FN13 (40 µg/ml) added to cells on 
unmodified SAM surfaces compared to FN13-tethered and unmodified SAMs. 
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FIGURE 4.7  Micropatterned substrates functionalized with FN13 peptide.  
Lanes composed of 19:1 EG3:EG6-Acid with a EG3 non-adhesive 
background.  FN13 functionalized lanes (10 µm wide with a 50 µm spacing) 




examined by detection of assembled type I COL fibrils within the FN 
architectures. FITC-labeled type I COL added to the culture media (1µg/mL) was 
visualized within FN matrices by immunofluorescent staining.  In excellent 
agreement with results indicating that FN13-functionalized surfaces directed FN 
matrix assembly, these surfaces assembled robust matrices with co-assembled 
FN and type I COL (Figure 4.8a). In contrast, control surfaces presenting no 
oligopeptides assembled minimal levels of FITC-COL, and cells seeded on 
scrFN13 and RGD-functionalized surfaces did not incorporate COL into their 
matrix.  The co-assembly of type I COL and FN matrices demonstrates the ability 
of the FN13-tethered surface to direct assembly of ECMs (Figure 4.8b).     
 
Peptide Dependent Bioactivity: Proliferation.  
To further investigate the peptide-dependent control over cell activities, 
cell proliferation rates were examined for ligand-functionalized surfaces.   
Assembled FN matrices have been shown to regulate cell cycle progression by 
modulating cell proliferation rates.10   Cells cultured for 24 hours on ligand-
functionalized substrates demonstrated peptide-dependent proliferation rates 
(Fig. 4.9).  FN13-functionalized surfaces showed nearly a two-fold increase in 
the number of proliferating cells (as determined by BrdU incorporation) compared 
to control scrambled peptide sequences, RGD functionalized substrates, and 
unmodified supports. Taken together, these results demonstrate that FN13-
functionalized surfaces promote the assembly of robust FN matrices mimicking 
the fibrillar structure and  biochemical characteristics of native ECMs.  These FN 
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FIGURE 4.8  Co-assembly of type I collagen fibrils within the FN matrices.    
Column (a) Type I COL matrix assembly on ligand-functionalized surfaces 
(COL = green, DNA = blue; scale bar 10 µm).  Column (b) Assembled matrix 
architecture for FN13-functionalized surfaces displaying co-assembly (FN = 





































FIGURE 4.9  Cell proliferation rates on ligand-functionalized surfaces.  a, Cells 
actively synthesizing DNA are stained green while all cellular DNA is counter 
stained red for total cell counts (scale bar = 200 µm).  b,  Quantification of 
proliferating cells after 24 hrs in culture on ligand-functionalized surfaces.  * vs. 
Unmodified (p < 0.0006). 
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matrices also regulate distinct cell functions associated with native ECMs.   
 
CONCLUSIONS 
 We have demonstrated that surface tethering of an oligopeptide sequence 
from the FN self-assembly domain promotes the assembly of fibrillar FN matrices 
compared to bioadhesive RGD-functionalized and control substrates.  This 
surface advances the field of biomaterials as the first biomimetic surface that 
actively promotes cell mediated ECM assembly.  Identification of a critical 
surface density of FN13 peptide provides substantial information for the rational 
design of next generation FN13-functionalized materials.  Cell-mediated FN 
matrices assembled on FN13 immobilized surfaces also direct the co-assembly 
of type I collagen matrices, and increases cell proliferation rates.  Given the 
critical importance of fibrillar FN structures in cell cycle and function, the 
development of such biomimetic surfaces provides a promising strategy for the 
engineering of bioactive ECM-mimetic supports for enhanced molecular control 
of cellular activities. 
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CONCLUSIONS AND RECOMMENDATIONS FOR FUTURE WORK 
 
The goal of this research was to engineer biomaterial surfaces that 
modulate cell-mediated assembly of extracellular matrices (ECM) in order to 
direct cell function.  The ECM plays a central role in tissue morphogenesis, 
homeostasis, and repair, and ECM characteristics are therefore worthy of 
mimicking to provide control of cellular activities on synthetic substrates.  The 
approach of controlling the cell-material interaction through the immobilization of 
bioactive peptides on a non-fouling support represents a versatile method to 
control cellular responses for biomaterial and tissue engineering applications.  By 
focusing on osteoblasts, the cells responsible for bone matrix production and 
mineralization, this research is relevant to the engineering of surfaces that may 
lead to improvements in biomaterials for orthopedic implants, bone grafting 
substrates and tissue engineering scaffolds.  By utilizing biochemical analysis of 
cellular assembled fibrillar matrices, we have contributed towards establishing a 
fundamental framework for the rational design of biomimetic surfaces to control 
cell function.   
A significant advantage of our experimental system over previous studies 
is the use of model surfaces consisting of SAMs of alkanethiols on gold 
presenting well-defined chemistries.  Using highly sensitive protein adsorption 
and cell adhesion assays, we demonstrate significant FN adsorption and cell 
adhesion to CH3/EG3 mixed SAMs, including pure EG3 monolayers.   We 
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developed a protocol for the removal of non-specifically adsorbed FN from these 
surfaces that was utilized to create non-fouling biomimetic substrates.   
Covalent-attachment of a short bioactive peptide (FN13) to a non-fouling 
background established a new class of biomaterial surface that actively promote 
the cell-mediated assembly of fibrillar ECMs.  Cells cultured on these surfaces 
co-assembly FN and type I COL matrices, and show increased rates of 
proliferation.  A defining characteristic to this surface is the threshold response of 
the peptide in promoting FN matrix assembly.  Above a critical surface density of 
0.009 pmol/cm2, the effect on FN matrix assembly was saturated.  This critical 
peptide density corresponds to a surface spacing of ~105 nm between FN13 
peptides, which is nearly equivalent to the length of an extended FN dimmer (90-
130 nm).  Overall, this thesis makes important contributions to the development 
and design of biomimetic surface modifications that direct cell function for 
biomedical and biotechnology applications. 
Recommendations for future experiments include many exciting 
possibilities.  Further examination of the FN13-induced FN matrix effect on 
additional cell functions represents an excellent starting point for future work.  
Examination of gene and protein expression as well as mineralization will allow 
for evaluation of osteoblastic differentiation.  FN is important for embryonic 
development and promotes differentiation of multiple cell types, while also 
playing a role in cancer metastasis.  It would therefore be of interest to examine 
the effect that FN13 had on promoting FN matrix assembly in other cell types.  
Similarly, assembled FN matrices play a significant role in the co-assembly of 
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matrix proteins and the binding of soluble growth factors.  The integrity of the 
FN13-induced fibrillar matrix could be further investigated by examining the 
ability to localize these soluble extracellular molecules.  In addition, it could be of 
interest to move this 2-D model system toward a 3-D scaffold.  Incorporation or 
attachment of FN13 peptide within a 3-D scaffold could promote matrix 
deposition within the scaffold, and promote cellular infiltration within the material.  
Finally, in vivo experiments with model surfaces should be conducted in order to 
address whether these surfaces similarly modulates cell response within the 







The purpose of this appendix is to further supplement the experimental 
details that appear earlier in text.  Previously mentioned experimental details 
were for journal submission.  This appendix explains the finer details in a 
systematic fashion for each of the techniques utilized for the completion of this 
work. 
In addition, a significant amount of time and effort was dedicated to the 
development of “mixed ligand” surfaces with presented both RGD and FN13 
peptides.  This immobilization of two peptides was done by sequentially tethering 
the RGD peptide for 30 min followed by the FN13 peptide for an additional 30 
min.  The original goal of this system was to identify possible synergistic or 
additive effects to surfaces that expressed both adhesion peptides to promote 
integrin-mediated initial adhesion, and the FN13 peptide that supports longer 
term effect in matrix assembly and cell proliferation (with the potential of 
additional functions).  This work was the basis for the discovery that the anti-
biotin antibodies were saturating on the surface before the peptides were.  We 
were unable to determine absolute densities of each peptide within these mixed 
ligand systems, and were unable to find an additional function that was specific 
to these mixed-ligand surfaces that was not obtainable with any single ligand 
system.  This was attributed to blindly guessing at what coating concentration we 
felt contributed to relative amounts of each peptide on the surface.  Because of 
this, we felt that it was not worth adding the unfinished work to the thesis as its 
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own chapter, but felt that it would best serve future lab members in the appendix 
as a potential starting point to future work.  For this reason, I am only including 
the data obtained from this system without additional write-ups.  The 
experimental procedure is the same as other experiments except for the 
additional step in assembling monolayers.  ENJOY! 
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Tethered Surface (µg/ml FN13)





















Results were analyzed by ANOVA using SYSTAT 8.0 (SPSS, Chicago, IL). If 
treatments were determined to be significant, pairwise comparisons were 
performed using Tukey post hoc test. A 95% confidence level was considered 
significant.  
 
Within a given FN13 coating concentration, there were no significant differences 
in adherent cell fractions 
 
 
Low initial adhesion to FN13 functionalized surfaces was the original reason for 
exploring mixed ligand surfaces… 
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Tethered Surface (µg/ml scrFN13)





















Results were analyzed by ANOVA using SYSTAT 8.0 (SPSS, Chicago, IL). If 
treatments were determined to be significant, pairwise comparisons were 
performed using Tukey post hoc test. A 95% confidence level was considered 
significant.  
 
Within a given scrFN13 coating concentration, there were no significant 
differences in adherent cell fractions 
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Tethered Surface (µg/ml RGD)





















Results were analyzed by ANOVA using SYSTAT 8.0 (SPSS, Chicago, IL). If 
treatments were determined to be significant, pairwise comparisons were 
performed using Tukey post hoc test. A 95% confidence level was considered 
significant.  
 
* vs. unmodified, (p < 0.000008) 





R G D  C oating  C oncentra tion  (µg /m L)



















0.00  µg/m l FN 13
0.78  µg/m l FN 13  
3.20  µg/m l FN 13
25.0  µg/m l FN 13
 
Results were analyzed by ANOVA within a given RGD concentration using 
SYSTAT 8.0 (SPSS, Chicago, IL). If treatments were determined to be significant, 
pairwise comparisons were performed using Fisher's Least-Significant-Difference 
Test. A 95% confidence level was considered significant. 
 
For each RGD concentration, there were no significant differences in cell 
adhesion for between FN13 concentrations except for RGD = 50 µg/ml. 
  
 
† RGD = 50 µg/ml vs. 25.0 µg/ml FN13 (p < 0.02) 
† 
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R G D  C o a tin g  C o n c e n tra tio n  (µ g /m L )



















0 .0 0   µ g /m L  s c rF N 1 3
0 .7 8   µ g /m L  s c rF N 1 3
3 .2 0   µ g /m L  s c rF N 1 3
2 5 .0   µ g /m L  s c rF N 1 3
 
Results were analyzed by ANOVA within a given RGD concentration using 
SYSTAT 8.0 (SPSS, Chicago, IL). If treatments were determined to be significant, 
pairwise comparisons were performed using Fisher's Least-Significant-Difference 
Test. A 95% confidence level was considered significant. 
 
For each RGD concentration, there were no significant differences in cell 
adhesion between FN13 concentrations.  
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Cell Adhesion Assay 
Cell adhesion to SAMs was measured using a centrifugation assay that applies well-
controlled detachment forces1.  SAMs were assembled in Au-coated Lab-Tek chamber 
slides and functionalized with controlled densities of bioactive peptides, and then blocked 
in 1% BSA for 1 h to prevent non-specific adhesion.  MC3T3-E1 osteoblast-like cells 
were labeled with 2 µg/mL calcein-AM and seeded at 200 cells/mm2 in 10% FBS in α-
MEM onto chamber slides for 45 min at 37 oC.  Initial fluorescence intensity was 
measured to quantify the number of adherent cells prior to the application of force.  After 
filling the wells with media and sealing with transparent adhesive tape, substrates were 
spun at a fixed speed in a centrifuge (Beckman Allegra 6, GH 3.8 rotor) to apply a 
centrifugal force corresponding to 92g.  After centrifugation, media was exchanged and 
fluorescence intensity was read to measure remaining adherent cells.  For each well, 





RGD Coating Concentration (µg/mL)
























Curve Fit in Sigma Plot with modified hyperbola R2 = 0.99 
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RGD Coating Concentration (µg/ml)



























FN13 0.78 µg/ml 
FN13 3.20 µg/ml 
FN13 25.0 µg/ml 
 
 
Results were analyzed by ANOVA using SYSTAT 8.0 (SPSS, Chicago, IL). If 
treatments were determined to be significant, pairwise comparisons were 
performed using Tukey post hoc test. A 95% confidence level was considered 
significant.  
 
Within a given FN13 coating concentration, there were no significant differences 
between RGD concentrations 
 
 118
FN13 Coating Concentration (µg/ml)






























Results were analyzed by ANOVA using SYSTAT 8.0 (SPSS, Chicago, IL). If 
treatments were determined to be significant, pairwise comparisons were 
performed using Tukey post hoc test. A 95% confidence level was considered 
significant.  
 
* RGD  = 50.0 µg/ml vs. 0.78 µg/ml FN13, 3.2 µg/ml FN13, 25 µg/ml FN13, (p < 
0.020) 
† RGD = 12.5 µg/ml vs. 3.2 µg/ml FN13, (p < 0.0049) 
%  RGD  = 1.6 µg/ml vs. 3.2 µg/ml FN13, 25 µg/ml FN13, (p < 0.0009)  




































































Results were analyzed by General Linear Model using SYSTAT 8.0 (SPSS, 
Chicago, IL). If treatments were determined to be significant, pairwise 
comparisons were performed using Tukey post hoc test. A 95% confidence level 
was considered significant.  
 
*    vs. Unmodified, (p < 0.02) 
†   vs. RGD – FN13 (25), (p < 0.0001) 
‡   vs. RGD – scrFN13, (p < 0.00008) 
$   vs. RGD, (p < 0.00003) 






Order here is the same as plot above 
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Trial #1 only   trial # did not stain correctly and needs to be redone… 
Results were analyzed by ANOVA using SYSTAT 8.0 (SPSS, Chicago, IL). If 
treatments were determined to be significant, pairwise comparisons were 
performed using Fisher's Least-Significant-Difference Test. A 95% confidence 
level was considered significant. 
 
*  Sig. vs. scrFN13, Unmodified, RGD-Fn13(25), and RGD-scr  p < 0.0006 






Preparation of substrates and gold deposition           
 There are two options when cleaning glass for gold deposition: 1) 
chemical cleaning, and 2) plasma Etching.  Each has its pros and cons.  
Chemical cleaning has no limitations to size (of the glass) but if not rinsed 
vigorously, this time intensive procedure leaves at least half of the substrates 
unusable due to salt formation.  However, this method obtains the cleanest glass 
when done properly.  Cleaning with the plasma etcher is very simple, but this 
method does not clean the glass as well.  Since the chemical cleaning can take 
the better part of a day, and it is obvious (slight dusty look on glass) when the 




1) Mix 70% H2SO4  w/ 30% H2O2 in beaker & place on hotplate heat (90 oC) 
2) Place glass coverslips into solution and submerge all floaters 
3) Let heat for 1 hour (check occasionally for floaters) 
4) Pour solution down drain with running water (use drain in hood) 
5) Rinse w/ diH2O several times to remove all salts (most important step) 
6) Rinse 2x in 70% EtOH AND 1x in 95% EtOH 
7) Remove coverslips and place on Al-foil; put in oven (70 oC for 0.5-1.0 h) 
8) Remove from oven and glue to TC dish lid with minimal ruber cement 
9) Coat with Ti and Gold (thickness depends on the experiment) 
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Plasma Etching (first written by Kristen Michael) 
1) With gloved hands, lift Pyrex cover at the handle.  Place samples on 
metal sheet under cover being careful not to scratch the rubber gasket.  
Cover sample platform with Pyrex 
2) Open Oxygen tank.  The regulator pressure should be just above 30psi 
3) Turn on “Vacuum Pump Power” switch.  This switch turns on both the 
vacuum pump & the water-cooling sump-pump.   
4) Adjust regulator pressure on controller to 20-30psi.  Turn the “System 
Vacuum” switch to on (switch is 3-position so turn to top position).  The 
vacuum gauge should read 30”Hg 
5) Turn the “Gas Control” switch on 
6) Adjust the flow meter to 2SCFH 
7) Adjust the power knob on the right face of the microwave to 100% 
8) Press “Time Cook” and set microwave timer to desired etch time (usually 
2 – 5 min cycles with 5 minutes cooling ) 
9) Shut off “Vacuum Pump Power,” “Gas Control,” and “System Vacuum” 
E-beam (first written by Kristen Michael)                                                                                       
1) Turn on water at the wall 
2) Turn on main power, and display power 
3) Open bell jar with switch. 
4) With gloved hands: 
a. Remove holder being careful not to hit the detector. 
b. Add sample to holder (will melt plastic if at the center). 
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c. Replace holder in bell jar and close bell jar. 
d. Close vent valve (labeled green, positioned behind bell jar). 
5) Lower Bell Jar and close tight 
6) Turn on mechanical pump power (will make a loud noise, pump down to 
< 2*10-6Torr). 
7) Set metal position to Ti.  (Set metal position by turning the rod at the 
right side of the bell jar.)  
8) Turn on substrate to turn sample holder while depositing metal 
9) Set controller to correct film and zero deposition thickness: 
a. Prog, ^, ^, film# = 1, Enter  (film# 2 for Au) 
b. Layer1 = 1, Enter  (layer1 = 2 for Au) 
c. Prog 
d. Start, Stop quickly (back to back) 
e. Reset (controller screen should say “Ready”) 
f. Zero 
10) Turn on the ion gun breaker switch and the ion gun emission controller 
11) Rotate emission level so that when the shutter is open (w/ N2), the 
deposition rate is ~ 2Å/sec 
12) When you reach the desired deposition thickness, close the shutter and 
turn emission level to zero slowly. 
13) After last metal, turn off shutter pump, deposition controller, and ion gun. 
14) Wait ~4min for metal to cool  
15) Turn off mechanical pump 
 124
16) Open vent valve at back of bell jar to return to 760 torr 
 
For all experiments but FTIR, 100 Å Ti and 150 Å Au.  For FTIR, 100 Å Ti and 
2000 Å Au. 
 
Reconstitution of Thiols 
1) THIOLS ARE VERY AIR SENSITIVE AND SHOULD BE STORED 
UNDER NITROGEN IN FREEZER PRIOR TO AND AFTER 
RECONSTITUTION  
2) MAKE ONLY ENOUGH TO USE AND DO NOT KEEP THIOLS IN 
SOLUTION LONGER THAN 2 WEEKS!!! 




Monolayers were assembled differently for each type of surface. 
 
Methyl and EG3 Mixed Monolayers 
1) Clean glass soaking in 95% EtOH for 30 min 
2) Dry gold under stream of N2 gas 
3) Fill clean container with enough thiol solution to completely cover gold  
4) Place gold into solution and let sit at room temp for 4 hours 
5) Rinse excess thiol away with 95% EtOH and dry under N2 gas 
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6) Soak in diH2O for 15 – 30 minutes 
7) Incubate in FN for 30 min 
8) Block in BSA for 30 min 
9) Elute in cPBS over night 
10) Seed cells at desired density 
 
EG3 and EG6-Acid Mixed Monolayers with Single Ligand 
1) Clean Au by soaking in EtOH for 15 – 30 minutes 
2) Assemble Mixed Monolayers of PEG3 and PEG6-Acid (solution = 
surface) for 4 hours on gold coated chamber slides  
3) Rinse with EtOH and soak in diH2O while preparing NHS solutions 
4) Soak in NHS solutions for 30 min 
a. Activation Buffer:  0.1 M MES, 0.5 M NaCl, pH 6.0 
b. EDC = 0.039g per mL Buffer needed (2mM total) 
c. NHS = 0.0119 p per mL Buffer needed (5 mM total) 
5) Add equal volume 40 mM solution of 2-mercapto ethanol (5 min, final 20 
mM) to quench EDC  
6) Tether ligands (peptide/ FN) to surfaces (30 min) 
7) Aspirate and quench remaining NHS with 20 mM Glycine (5-10 min) 
8) Aspirate and Block w/ 1% H.D. BSA (30 min) 
9) Aspirate and incubate in complete PBS overnight (in incubator) 
***  At this point, surfaces can be used for any of the experiments  
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EG3 and EG6-Acid Mixed Monolayers with Mixed Ligands 
 At this point of the project, it was a goal to remove the overnight 
incubation in cPBS for this mixed monolayer system.  This treatment of the 
surfaces added an additional day to each experiment for the set-up.  ELISAs 
were performed for different conditions including ranges in monolayer assembly 
time and elution in cPBS over night.   It was determined that the thiols could be 
assembled overnight and the16 h PBS treatment could be removed.   
 
1) Clean glass by soaking in EtOH for 15 – 30 minutes 
2) Assemble Mixed Monolayers of PEG3 and PEG6-Acid (solution = 
surface) for 4 hours on gold coated chamber slides  
3) Rinse with EtOH and soak in diH2O while preparing NHS solutions 
4) Soak in NHS solutions/ and or NHS Buffer for 30 min 
a. Activation Buffer:  0.1 M MES, 0.5 M NaCl, pH 6.0 
b. EDC = 0.039g per mL Buffer needed 
c. NHS = 0.0119 p per mL Buffer needed 
5) Add 40 mM solution of 2-mercapto ethanol (5 min, final 20 mM) to 
quench EDC  
6) Tether RGD (at various densities) to surfaces (30 min) 
7) Tether either FN13 or scrFN13 to surfaces (various densities, 30 min) 
8) Aspirate and quench remaining NHS with 20 mM Glycine (5-10 min) 
9) Aspirate and Block w/ 1% H.D. BSA (30 min) 
10) Aspirate and either seed cells or start ELISA 
 127










































NHS 4 hr ass no pbs
No NHS 4 hr ass no pbs
 



















NHS O.N.ass no pbs




X-ray Photoelectron Spectroscopy (XPS) and contact angle measurements were 
described in the appropriate chapter.   
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FTIR On SAMs (Smart SAGA) 
THESE EXPERIMENTS ARE VERY TRICKY AND SENSITIVE 
1) Gold for monolayer assembly must be completely reflective so that the IR 
beam does not pass through and lose signal. 
2) Coat VWR micro cover glasses 1 once, CAT NO. 48393 059;  22X50mm 
glass cover slips with 50 Å Ti and 2000 Å Au. 
3) Treat gold in same manner as for other experiments in both storage and 
monolayer assembly (and for NHS formation). 
 
FTIR Set Up 
1) Open bench door and remove Sample holder 
2) Insert Smart SAGA Accessory 
3) The instrument should tell you that the SAGA was inserted and ask if you 
want to run checks….   Click o.k. 
4) This will give you errors and tell you that it does not meet the required 
settings… click o.k. or cancel. 
5) Go to Collect on dropdown menu and click on Experimental Setup 
6) This menu has several tabs:  Collect, Bench, Quality, Advanced, and 
Diagnostic.   Make sure that they read as follows 
a. Collect:   
i. No of Scans = 1024 
ii. Resolution = 4 
iii. Final Format = % Reflectance 
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iv. Corrections = None 
v. Check the box next to Auto Atmosphere correction 
vi. Check the box next to Collect Background before each sample 
b. Bench: 
i. Set to Auto Gain 
ii. Velocity = 0.1581 
iii. Check the box next to min/max 
iv. Sample Compartment = Main 
v. Detector = DTGS KBr 
vi. Beam splitter = KBr 
vii. Source = IR 
viii. Accessory = SMART SAGA 
ix. Window Material = Ge 
x. Range = 4000-600 
c. Quality: 
i. Check box next to spectrum 
ii. Uncheck box next to “Use spectral quality checks” 
d. Advanced and Diagnostic:  No need to touch these! 
7) Place clean gold sample w/o monolayer for a background scan.  Aperture 
should be set to open and corresponding mask should be used 
8) The bench will not give a reading unless gold is on holder (face down) to 
reflect the beam 
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9) Purge System for 2 hours before taking a background scan.  Check bench 
purge; run a scan with less scan numbers on blank gold as background 
and sample.  If spectra is straight line, then system is purged 
10) Once purged, click on Collect on drop down menu and then on Collect 
Sample 
11) This will ask you to name window… name it and click ok 
12) Collection will take about 1h and 6 min.  After finished, remove blank gold 
and place sample face down on SAGA.  Let purge for almost one hour to 
remove introduced moisture and CO2. 
13) Click ok on the box asking you to begin scan on sample. 
14) After 1 h and 6 min.  It will ask you to add it to the window that was in the 
drop down menu during the scan.  Can’t change after scan is complete! 
15) Play with spectra as you like.  Smooth, baseline correct, ect… 
 
























PIERS spectra acquired for (a) a confluent SAM of 1, (b) a mixed SAM 
composed of 1 and 2 (χ (1) = 0.95), (c) a mixed SAM composed of 1 and 2 (χ (1) 
= 0.95) after activation with NHS and EDC to form the corresponding NHS ester. 
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(a) No bands in this region, as expected for PEG surface 
(b) The band at 1621 is assigned to the C = O stretch for carboxylic acid groups 
(c) The band at 1741 is assigned to the asymmetric stretch of the NHS carbonyls, 
while the band at 1780 is assigned to the symmetric stretch of the NHS carbonyls, 
and the band at 1819 is assigned to the stretch from the activated ester carbonyl 
group. 
(d) The band at 1723 is assigned to the C = O stretch for the carboxylic acid 
groups associated with hydrolyzed NHS esters, while the band at 1659 is 















Introduction of Bio-ligands and Proteins 
 
 For -EG3 and –CH3 terminated alkanethiol mixed monolayers, the bio-
ligand of choice was FN.  We used radio-labeled FN for ultra-sensitive 
measurements. 
 
Quantification of Fibronectin on Monolayers (125I-FN Study): 
Iodinating FN with Bolton-Hunter Reagent (below): 
 
Day 1: 
1) Make 0.1M NaB solution and pH to 8.5 (sterile) 
2) Reconstitute 1g of FN with 100 µL of above solution 
Bring Bolton-Hunter Reagent to Radioactive center and in hood, 
behind lead… 
3) Remove lid  and insert 23-gauge needle (connected to charcoal trap) 
through the septum 
4) A second needle is inserted through the septum with a gentle stream 
of Nitrogen to evaporate the benzene solvent (CAREFUL WITH FLOW 
TO PREVENT SPLASHING!!!) 
5) Add 10 µL#2 above through the septum with a syringe and let incubate 




   O 
   O 
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   N 
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PREPARE Sephadex-25 Column: 
1) Fill 50 mL conical vile with 0.5g sephadex-25 beads and add 1 mL 
1%HD BSA, 1 mL 10% Azide, 20 mL di H20. Place on rocking plate for 
several hours, then put into fridge overnight….  Incubate overnight to 
block for adsorption of the FN to the beads 
2) Next day (packing column):   Take 1 mL syringe and pull it apart. 
3) Fill syringe up to the 0.9 mL make with the sephadex solution 
4) Rinse 5X with complete PBS to remove excess BSA 
 
Day 2: 
1) Quench the reaction by adding 50µL of 0.2 M glycine in the 0.1 M NaB 
buffer (pH = 8.5) 
2) Set up sephadex-25 column on stand and let eluant run off until level 
with top of beads. 
3) Load the solution from the reaction vial. 
4) Let six drops collect into one tube, then begin collecting 2 drops/ 
fraction 
5) Collect fractions until get two spike in radioactivity with Geiger counter 
6) 1st spike if the labeled FN and second is the unreacted Bolton-hunter 
reagent (column is size exclusion so that the small gets trapped in the 
sephadex and comes off slower) 




1) Take 1 µL and drop entire pipette tip into a glass test tube 
2) Run Protocol #6 FN ADSORPTION on above and empty test tube 
 
Specific Activity =  CPM / µg    reading from above is CPM / µl 
 
Ex:   reading = 1170416 CPM / µl 
            0.613 µg / µl (concentration from nano-orange ) 
 
S.A. = 1.9 X 106  CPM / µg 
 
Other calculations are needed for safety sheet and are on page 95 of book 
01-2 
 
Nano Orange (Protein Quantification Technique): 
 
Perform 1st on BSA as test of technique and of Nano Orange’s Efficiency  
***  Follow protocol from Molecular Probes Sheet 
1) Mix 9 µl Component A, 450 µl Component B in 4.05 mL di H2O 
2) 4.5 µl (2 µg/ µl BSA, C) in 895.5 of #1 
 
Put 225 µl of #2 into four vials…  
Two are at 10 µg/ µl the other two are used to make serial dilutions 
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Leave in the vials and put in water bath @ 90 oC for 10 min 
 
Centrifuge down and pipette 200 µl into black dish 
 













Nano Orange on “HOT” FN-125I 
 
1) Mix 9 µl Component A, 450 µl Component B in 4.05 mL di H2O 
2) 8.0 µl (1 µg/ µl cold FN) in 792 of #1  [ diluted 1: 100 gives 10 µg/ mL ] 
3) Make serial dilutions of #2 about (10, 5, 2.5, 1.25, …) 
4) Place 200 µl / well into black dish… 
5) Take 2 µl of unknown concentration of HOT—FN and add 198 µl #1. 
6) Read in plate reader at Gain = 60, Absorbance = 470  Emission = 570 
7) Fit unknown into curve to determine the 1:100 diluted concentration 
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To demonstrate that the iodination procedure did not alter the activity of the 
protein, control adsorption experiments with different ratios of labeled and 
unlabeled protein were performed.  (see page 102 of 01-02) 
1) Make 5 µg/ ml solution of FN at varied ratios of hot to cold FN and read 
radioactivity adsorbed to glass following protocol for FN adsorption.   
2) Ratio of signals should correspond to the ratio used in solution 
 
FN Adsorption to SAMs: 
1) SAMs were assembled on Au-coated 9 mm2 glass cover slips and pre-
soaked in diH2O for 30 min.   
2) Samples were then immersed in 125I-FN solutions (mixed with 
unlabeled FN in PBS) for 1 h.   
3) After removing FN solutions, samples were immersed in 1% BSA (1 h).   
4) Samples were transferred to clean tubes and radioactivity was 
measured using a gamma counter.   
5) Adsorbed 125I-FN was quantified as radioactive counts (cpm) and 
converted to adsorbed FN surface densities (ng/cm2).   
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6) For FN elution studies, samples were coated with FN and BSA as 
described above, then incubated in PBS or 10% NCS in DMEM for 1 h 
or 16 h, and the remaining FN adsorbed on the sample was quantified. 
 
χEG3






















ELISA for Immobilization of Peptides to Mixed -EG3 and -EG6-Acid SAMs: 
Example: Biotinylation of  KGGGFN13 
Use Pierce EZ-Link ™ PEO-Maleimide Activated Biotin 
Reagents: 
1) Phosphate/EDTA Buffer – 100 mM sodium phosphate, 5 mM EDTA; pH 
6.0 
2) Phosphate Buffered Saline (PBS) – 0.1 M sodium phosphate, 0.15 M 
NaCl; pH 7.2, 1 mM EDTA 
3) Make 1 mg/ mL solution o peptide in # 1 above 
4) Make a 10 mM solution of PEO-Biotin in # 2 above 
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5) Add 50 mL of # 4 above to # 3 above and let sit in dark at room 
temperature over night 
 
FN 13 tethering to SAMs protocol:  
 
1)  Assemble Mixed Monolayers of PEG3 and PEG6-Acid (solution = surface) 
for 4     hours on gold coated chamber slides  
2) Rinse with EtOH and soak in diH2O while preparing NHS solutions 
3) Soak in NHS solutions/ and or NHS Buffer for 30 min 
a. Activation Buffer:  0.1 M MES, 0.5 M NaCl, pH 6.0 
b. EDC = 0.039g per mL Buffer needed 
c. NHS = 0.0119 p per mL Buffer needed 
4) Aspirate and quench EDC with 20 mM solution of 2-mercapto ethanol (5 
min) 
5) Tether FN13 peptide to surfaces (30 min) use serial dilutions of both “hot” 
and “cold”  in complete PBS 
6) Aspirate and quench remaining NHS with Glycine (5-10 min) 
7) Aspirate and Block w/ 1% H.D. BSA (30 min) 
8) Aspirate and incubate in complete PBS overnight (in incubator)  
9) Rinse with diH2O 3X and aspirate 
10) Incubate in 60 µl of α-biotin-alkaline phosphatase (1:10,000) in 5% FBS – 
azide blocking buffer (1 h @ 37oC in incubator)  
11) Rinse 3X in diH2O then block for 10 min in FBS buffer 
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a. FBS buffer = 5 mL FBS, 1 mL 10% NaN3, fill to 100 mL with PBS 
12) Rinse 3X with diH2O add 60 µl 1X DEA solution while preparing substrate 
(at least 10 min) 
a. 1X DEA = 2 mL 5X DEA (stock in fridge), 8 mL diH2O 
b. 5X DEA = 600 µl diethanol amine, 0.0519g Mg.6H2O 
i. bring to 100 ml w/ di H2O (sterile) 
ii. pH to 9.5 w/ 1N HCl and store at 0 oC 
13) Aspirate and add 60 µl MUP solution to each well 
a. 8 mL MUP solution = 6.0 mL diH2O, 400 µl NaCO3H, 2 mL 5X DEA, 
19.2 µl MUP substrate 
i. MUP substrate = make 25 mg MUP (stored in -20) with 1 mL 
of 1X DEA solution 
14) Use multi-well pipette to suck off as much as possible and place into black 
dish (store chamber slides in dark in buffer while reading) 
15) Read on plate reader: 
a. Parameters: 
i. Fluorescence;  Plate definition = dynex96black.pdf 
ii. Excite 360, Emission 465 
iii. Gain 40, manual, read from top 
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FN Peptide Coating Concentration (µg/mL)
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Χ 0.95 NHS bFN13 
Χ 0.95 no NHS bFN 
Χ 1.0 bFN 
 
 
Radio labeling Peptides for Absolute Measurements of Immobilized 
Peptides to Mixed -EG3 and -EG6-Acid SAMs: 
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Iodination of FN peptides (KGGGAHEEICTTNEGVMY, and GRGDSPCY) 
using Na125I (Anal. Chem. 187, 292-301 (1990)).   
 
Synthesis involves 1mCi (for each peptide) of 125I-containing Na125I reagent 
(Amersham Biosciences, Piscataway, NJ).  Iodination will be preformed 
according to protocol using IODO-GEN®  Pre-Coated Iodination Tubes.  
Iodination and purification will be performed in NNRC RCZ and purified 125I-FN 
peptides will be transported to 107 SSTC in a sealed tray with lid. 
 
 
1. Two IODO-GEN® Pre-coated reaction tubes were wet with 1ml of High Tris 
Buffer (0.125 M Tris•HCl, pH 6.8, 0.15 M NaCl), and decanted.   
 
2. 100 µl of Tris Buffer was added to the first tube as a reaction solvent. 
 
3. 10 µl (1 mCi) of Na125I (Amersham IMS-30, in 50 µM NaOH) was added to 
the first IODO-GEN tube to activate Iodine (6 minutes at room temperature, 
flick every 30 sec.). 
 
4. The full reaction volume was transferred to the second IODO-GEN® Pre-
coated reaction tube and 6 minute flicking was repeated. 
 
5. 55 µl (0.50 mCi) added to each peptide solution = React for 10 min at 
room temp with gentle flicking every 30 seconds, then let react overnight 
@ 4 oC. 
 
6. peptide solutions  =    
• FN13-Y = 321 µl of a 1.09 mg/ml solution in TRIS buffer (350 
µg) 
• RGD-Y = 101 µl of a 1.58 mg/ml solution in TRIS buffer (160 µg)   
• Each peptide received 55 ul of Iodine solution to bring their final 
concentrations to around 1 mg/ml 
 
7. Reaction is NOT QUENCHED with adding tyrosine since tyrosine gives 
background signal in the spec when determining peptide concentration 
and it is not successfully separated from the peptides on the columns. 
 
8. add 0.38 ul of TFA to FN13 to bring to 0.1% TFA before loading onto 
column add 0.16 ul of TFA to RGD to bring to 0.1% TFA before loading 
onto column 
 
9. Labeled FN peptides (125I labeled peptide) were separated from the 
unreacted Na125I by reverse phase column chromatography using a Sep 
Pak C18 Light  column (Waters, Milford, MA).  Fractions will be collected 





1) wash with 3 ml MeOH 
2) stabilize with 4 ml TRIS Iodination Buffer with 0.1% TFA  
3) load sample slowly in 0.1% TFA (drops and let creep onto column) 
4) rinse with 3-4 ml TRIS buffer (w/ 0.1% TFA) 
5) 2 ml each Eluant (collect all 2 ml as one fraction) 
 Eluants: 
a) 10 % MeOH : 89.9 % Water; 0.1% TFA 
b) 20 % MeOH : 79.9 % Water; 0.1% TFA 
c) 30 % MeOH : 69.9 % Water; 0.1% TFA 
d) 40 % MeOH : 59.9 % Water; 0.1% TFA 
e) 50 % MeOH : 49.9 % Water; 0.1% TFA 
f) 60 % MeOH : 39.9 % Water; 0.1% TFA 
g) 70 % MeOH : 29.9 % Water; 0.1% TFA 
h) 80 % MeOH : 19.9 % Water; 0.1% TFA 
i) 90 % MeOH : 9.9 % Water; 0.1% TFA 
j) 99.9 % MeOH : 0.0 % Water; 0.1% TFA 
k) 100 % MeOH 
 
Scan each fraction for radioactivity, pull vacuum on open vials to remove as 
much MeOH as possible before determining concentration with spec, or activity 
with gamma counter 
 
Spec each fraction with UV Vis @ 280 
 
Spicy RGD   RDG-Y  extinction coeff = 1.14 
FN13-Y   extinction coeff = 0.74 
 
This column was unable to completely remove free iodine from the reaction 
mixture, and lead to very large background signal that swamped out tethering 
profiles.  GOOGLE lead me to a company called Millipore (Billerica, MA).  The 
have a filtration system called the “Stirred Cell”(cat no. 5125, 3 mL volume) which 
can use filters with a 500 Da cut off (cat no. 13012).  Since the filter membranes 
have a 10% alcohol limit, samples were diluted to decrease % MeOH from first 
column.  After loading 3 mL at a time (running down to 0.80 mL before reloading), 
and washing with 20 + mL of water in the same manner, 34 µg of the 110 µg 
loaded were recovered.  This fraction had a S.A. of over 280,000.  It was used for 
both single ligand-tethering profiles, and for mixed ligand systems in which Hot 
RGD was tethered first and cold FN13 second.  There was a slight amount of 
free iodine left, so control surfaces of EG3 were included for each coating 
concentration to subtract out free iodine binding to gold. 
 
The FN13 peptide had high levels of free iodine after a first pass through the 
Millipore filters.  The first run recovered 110 µg of the 300 + µg loading.  The S.A. 
was a rather poor 28,000.  A second attempt at removing the free iodine from the 
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FN13 fraction resulted in complete loss of the peptide to the filter.  U.V. spec 
analysis showed no detectable levels of FN13 in any fraction off the column, or in 
the filter bed.  Since the filter is reading very HOT, it suggests adsorption to the 
filter membrane.   
 
I would only suggest using these membranes if large levels of high S.A. peptides 
are expected, and if the sample has no alcohol to require dilution (*Membranes 




NIH 3T3 Mouse Fibroblast: 
Media: 
10 mL NCS,  1 mL P+S,  fill bottle to 100 mL w/ DMEM 




10 mL FBS,  1 mL P+S,  fill bottle to 100 mL w/ DMEM 
Split ratio varies depending on cell proliferation rate. 
 
MC3T3-E1 Osteoblast like cells 
Media: 
10 mL FBS,  1 mL P+S,  fill bottle to 100 mL w/ DMEM 
Split ratio varies depending on cell proliferation rate.  IT IS VERY IMPORTANT 
THAT CELLS SIT IN TRYPSIN FOR 1 MINUTE AND BANG PLATE TO 
REMOVE.   THIS ALLOWS FOR MAXIMUM FN ON THE SURFACE OF THE 
CELL TO AIDE IN INITIAL ADHESION TO SURFACES. 
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Immunofluorescent Staining: 
 This section is a general description of the immunofluorescent staining 
process, and meant to supplement specific procedures within chapters. 
 
Solutions / Buffers: 
Blocking Buffers: 
1) 1 % H.D. BSA (use when staining for ECM proteins) 
a. 100 mL 1 % H.D. BSA solution 
b. 1 mL 10 % Sodium Azide (keeps sterile by interfering with the 
electron transport system) 
2) 5 % NCS  (use when not staining for ECM proteins) 
a. 5 mL NCS 
b. 1 mL 10 % Sodium Azide  
c. Fill to 100 mL line with PBS complete 
3) 5 % FBS (use when not staining for ECM proteins) 
a. 5 mL FBS 
b. 1 mL 10 % Sodium Azide  
c. Fill to 100 mL line with PBS complete 
 
Cross-linking / Fixing: 
1) 3.6 % Formaldehyde  (store in fridge in Al foil) 
a. 10 mL of the 36% Formaldehyde stock solution 
b. 90 mL PBS complete 
 146
2) CSK Solution 
a. 5 mL 1 M Tris –HCl 
b. 0.29 g NaCl 
c. 5.14 g Sucrose 
d. 61 mg Mg.Cl2.H2O 
e. pH to 6.8 
f. Fill to 100 mL line on bottle with di H2O 
3)  CSK + Triton X Solution (chemical shelf, -20 oC on shelf, -20 oC 1D12) 
a. 10 mL CSK solution d. 350 µL 2mM PMSF 
b. 50 µL Triton-X-100 e. 200 µL Aprotinin 
c. 10 µL Leupeptin 
 
Permeablize Cells: 
1) Aspirate culture media 
2) Add 1 mL CSK + Triton X Solution to each well/ sample  (solution should 
be cold; 5-10 min then aspirate) 
3) Add 0.5 – 1.0 mL of cold 3.6% CH2O to each sample; incubate 5- 10 min 
4) Block with appropriate blocking buffer for 5-10 min and aspirate 
5) 1o Anti bodies should be diluted to appropriate concentrations in blocking 
buffer and cover the sample with correct volume.  Let incubate for 1 hour 
6) Wash 3X with PBS and incubate for 5 – 10 minutes in blocking buffer 
7) 2o α-bodies diluted to appropriate concentrations in blocking buffer and 
cover the sample with correct volume.  Let incubate for 1 hour in the dark 
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8) Wash 3X with PBS 
9) Mount with Gel mount to slide with a cover-slip face up, and let dry 
10) Nail polish edges of cover-slip with clear nail polish to prevent dehydration 
 
Staining w/ anti-bodies: 
1) 25 µL / 9mm2 cover slip 
2) FN = 1o rb α-poly FN (1:400, -20 oC 1D11), 2o α−rb Tx –Red (1:200, blue 
case 2nd shelf -20 oC) 
3) α5 = mouse α − α5 (1:250, -20 oC), 2o  α− ms Alexa Fluor 488 (green) 
(1:200, blue case 2nd shelf -20 oC) 
4) DNA = no primary, only 2o Hoechst (1:10,000, fridge in Al foil) 
5) Vinc = ms- α−Vinc  (1:100, -20 oC 1D10), 2o  α− ms Alexa Fluor 488 
(green) (1:200, blue case 2nd shelf -20 oC) 
6) F-actin = No primary, 2o rhodamine phalloidin (1:200, blue box -20) 
 
 
Cell Adhesion Assay 
 Cell adhesion to SAMs was measured using a centrifugation assay that 
applies well-controlled detachment forces.  SAMs were assembled in Au-coated 
Lab-Tek chamber slides.  Cells (NIH-3T3 or MC3T3-E1) were labeled with 2 
µg/mL Calcein-AM and seeded at 200 cells/mm2 in serum containing media onto 
chamber slides for indicated times either at room temperature or 37 oC.  
Substrates were spun at a fixed speed in a centrifuge (Beckman Allegra 6, GH 
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3.8 rotor) to apply a centrifugal force.  For each well, adherent cell fraction was 
calculated as the ratio of post-spin to pre-spin fluorescence readings.   
 
Prepare Substrates 
1) Chamber slides are disassembled by removing the chambers and treated 
as follows: 
2) Pop chambers off of slide 
3) With Razor Blade, remove extra PDMS from corners and from tall center 
spot 
4) Place into Plasma Etcher and turn to 100% power 
5) “COOK” for 5 min, rest 5 min, and “COOK” for 5 min more 
6) Tape with Kapton directly onto sample holders in the ebeam 
7) Coat with 100 Å Ti, and 150 Å Au 
 
            
 
Protocol does not need to be sterile since adhesion for at most 1 h 
1) Assemble monolayers according to surface type 







Cell Culture - Seeding 
1) Aspirate Serum from cells 
2) Rinse with complete PBS 
3) Add 10 µl of Calcein-AM in 5 mL 2mM Dextrose PBS (1D9) for 100 mm 
dish 
4) Let incubate for 20 minutes 
5) Aspirate and detach cells from dish 
6) Then seed cells in serum (NIH = 1 h @ 200 cells / mm2, MC3T3 =  45 min 
@ 800 cells / mm2) on bench top (60 µl / well). 
Spinning 
1) Glue chamber slides to the lid o a 96 well dish making sure that holes line 
up;  try not to get glue under wells 
2) Read plate on plate reader  Excite 494, Read 517 10 min after seeding 
3) After total adhesion time (45 min MC3t3 or 1 h for NIH),  use vacuum 
grease to put chambers back on wells 
4) Fill each well with cell culture media (240 µl) 
5) Put transparent tape across the wells to seal in fluid 
6) Place upside down into centrifuge and spin @ 92g (1000 rpm for 2 min, for 
MC3t3),  (46g / 500 rpm for NIH) 
7) Aspirate wells and add back 60 µL cell culture media to each well 
8) Reread in plate reader  




Cell Proliferation on Mixed Monolayers:   
SYBR® Green: 
 This method for cell adhesion is very poor due to DNA “clumping” 
  
1) 35 mm tissue culture dishes are taken directly from package and placed 
into e-beam 
2) Coated with 50 Å Ti and 150 Å Au 
3) Dishes and lids were placed into sterile hood, separated and placed face 
up 
4) Lamp was turned on for 30 min to sterilize 
5) Assemble monolayers as previously described 
6) Seed cells (@ 150 cells/ mm2 (144,317 cells / 35 mm dish, in 2 mL)  
7) Have duplicate samples for each day interval tested 
8) At each time point, take pictures of dishes (phase contrast) 
Adsorbed FN Density (ng/cm2)








































9) Rinse 3X with complete PBS (***this needs to be more reproducible next 
time) 
10) Take more pictures and aspirate 
11) Add 120 µL of Lysis buffer to each dish and let incubate at rat. for 30 min 
LYSIS BUFFER:  0.1 % SDS, 0.1  M Triton X in PBS (w/o ions) 
12) Use cell scrapper to remove cells. 




Quantification of Cell Number: 
1) Make a standard curve to correlate absorbance on plate reader to cell 
number 
a. Seed controlled number of cell onto 35 mm TC dish for 30 min (1/2 
million) 
b. Once cells are stuck to dish, treat as about to harvest DNA of 
control number of cells 
c. Take 40 µL of the ½ million cell’s DNA stock (from steps a & b) add 
to it 160 µL TE buffer ( 10 mM Tris-HCl, 1.0 mM EDTA in di H2O, 
pH 8.0) 
d. Make serial dilutions from step C above putting 100 µL into each 
well on black dish and adding 100 µL of TE buffer back to dilute cell 
count in half (perform in triplicate for stats and error) 
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2) Sample preparation 
a. Place 20 µL of stored cell lysates into each well on black dish 
(perform in triplicate for each sample) 
b. Mix TE and stock SYBR Green® (80:1.2) and place 81.2 µL of 
solution into each well containing sample 
c. Place 1.2 µL of SYBR Green® into wells containing standards 
 




 This method for cell proliferation is very simple, but is indirect.  It also 
interferes with other processes within the cell and can alter the natural cell cycle.  
Should try another means for proliferation.   
1) Monolayers assembled as previously described on 25 mm round cover 
slips each in a TC six well dish 
2) Next day, transfer cover slips to Ultra-Low Adhesion TC dishes 
3) Seed Cells (MC3T3-E1) in 10% FBS, 1% PS, α MEM @ 25 cells/mm2 
(Use area of 35 mm dish (A=962.11 mm2) for seeding area.) 
4) Add ALAMAR BLUE dye to make 10% of final volume in well (add 200µL 
to 2 mL seeding volume) five minute after seeding.  This should ensure 
that all cells are about at the same state since there are different cell 
attachment rates. 
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5) Have well with no cells, but same ratio of media to dye to obtain 
background and track self degradation of dye 
6) After 30 minutes, read the entire 6 well dish in the plate reader.  (d(0)) 
a. Fluorescence mode, Gain 40 or 60,  Excite 485, Emission 595 
7) Read again at d1, d2, and d3.  Any longer and cell metabolic activity can 
decrease since no media changes. 
 
BrdU Incorporation:    
 I found that this method for measuring cell proliferation was the best 
combination of ease of experiment and directness of the measurement.   
 
1) Monolayers were assembled overnight on 25 mm circles coated with 100 
Å Ti, and 150 Å Au  (done in triplicate for each condition). 
2) Assembled SAMs were treated as previously described to tether 
controlled densities of peptides, and block with BSA prior to cell seeding. 
3) MC3T3-E1 cells were seeded at 50 cells/ mm2 (cells had been 
synchronized by growing to confluence, then exchanging culture media 
with 0.5% BSA, 1% P+S, in αMEM for 3 day prior to seeding). 
4) After 16h in culture, media was gently exchanged with media 
supplemented with BrdU at a final concentration of 3.1 µg/mL (from 
1000x stock in water).   
5) Cells were pulsed with BrdU for 3.5 h, then washed 2x with cPBS 
6) Fix for 10 min with cold 70% EtOH 
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7) Wash 2x with cPBS 
8) Denature DNA with 4 N HCl for 20 min, followed by 2x cPBS wash 
9) Block with 1% H.D. BSA for 10 min 
10) Stain, 1o ms anti-BrdU (Becton Dickinson, Cat # 347580) (dilute 1:3.5 in 
1% BSA), 45 min in incubator. 
11) Rinse 2x with cPBS 
12) 2o = anti-ms IgG (Alexa Fluor 488, Molecular Probes) 1:200; and Eth 
Homo Dimer-2 1:1000 (Molecular Probes)  
13) Rinse and Mount 
14) Visualize and take 15-20 representative pictures per sample 
15) Use Image Pro to separate green and red channels and count nuclei 
16) Report as fraction of proliferating cells (over that 3.5 h time point). 
 
 





































Quantification of Assembled FN Matrix by Western Blot 
 This is the best method to determine biochemically if FN has been 
incorporated into the insoluble ECM.  DOC insoluble fractions under reduced 
conditions give the best result since they separate out soluble FN and reduced 
high molecular weight multimers so that they can run properly on the gel. 
 
Day 0 (can also be same day cells are Lysed) 
1. Make Buffers, Reagents and Gels  
a. DOC Lysis buffer 
i. 2% deoxycholate 
ii. 0.02 M Tris HCl (pH 8.8) 
iii. 2 mM PMSF 
iv. 2 mM EDTA 
v. 2 mM iodoacetic acid 
vi. 2 mM N-ethyl-Maleimide 
b. DOC Solubilizing Solution 
i. 1% SDS 
ii. 25 mM Tris-HCl (pH 8.0)  
iii. 2 mM PMSF 
iv. 2 mM EDTA 
v. 2 mM iodoacetic acid 
vi. 2 mM N-ethyl-Maleimide 
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c. Solutions for GELS 
i. (A) 50% acrylamide/BIS (29:1)  
1. 50 g 29:1 Bisacrylamide 
2. bring to 100mL w/ water, store in fridge up to 2 months in 
foil 
ii. (B) Separating GEL Buffer (1M Tris-HCl pH 8.8) 
1. 30.3 g Tris-HCl in 150 mL water, pH 8.8 
2. bring to 250 mL in water 
iii. (C) 10 % SDS 
1. 10 g SDS in 100 mL water 
iv. (D) Stacking GEL Buffer (0.375M Tris-HCl pH 6.8) 
1. add 11.4 g Tris to 150 mL water; pH to 6.8 and bring 
water to 250 mL 
v. (E) Catalyst (make fresh on the day of use) 
1. 100 mg of ammonium persulfate in 2 mL of water 
vi. (F) 50% Sucrose 
1. 50 g Sucrose; bring up to 100 mL with water 
d. Prepare 6X Protein loading Buffers 
i. Make 4X Tris-HCl SDS 
1. 6.05 g Tris + 40 mL water  pH 6.8 bring to 100 ml with 
water; filter with 0.45 µm filter and add 0.4g SDS 
ii. 6X Reducing Loading Buffer 
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1. 7 mL 4X Tris-HCl SDS; 3.8 g Glycerol, 1g SDS,  0.93 g 
DTT 1.2 mg bromo phenol Blue 
2. bring up to 10 mL with water 
iii. 6X NON-Reducing Loading Buffer  
1. SAME AS ABOVE W/O DTT 
e. 10 X Running Buffer 
i. 240 mM Tris (base), 192 M glycine, 1% SDS in water 
1. 29 g Tris (base), 144 g glycine, 10g SDS 
2. bring up to 1 L  with water 
f. 10 X Glycine for Transfer Buffer 
i. 30.3 g Tris Base, 144.1 g glycine; bring to 1 L with water 
 
2. Preparing Separating Gels (makes 2.5 gels) 
a. 5% Separating Gels 
i. 2.5 mL (A); 9.4 mL (B); 250 µl (C); 4 mL (F); 8.3 mL water; 625 
µl TEMED; 625 µl (E) 
ii. fill cassette to the second from the top line and over lay with 
water to help release bubbles 
iii. polymerize for 1-1.5h 





3. Stacking GELS 4% 
a. 1 mL (A); 125 µl (C); 4.2 mL (D); 6.3 mL water; 5 µl TEMED; 1 mL  
(E) 
b. fill to the top of the cassette with the stacking solution and insert a 
comb 
c. let solidify for 30 min    
d. can let sit on bench over night if using the next day, but stores in 
fridge for 3-4 d 
 
SAMPLE COLLECTION (Day 1) 
1. Aspirate media 
2. Wash 2X with complete PBS 
3. Add 250 µl  of DOC lysing reagent to a 35 mm well; let sit for 10-20 min  
4. Scrape with a cell scraper and collect lysates into a micro centrifuge tube 
a. Pipette up and down 25 times to shear DNA with the R-100 pipette 
5. Centrifuge >14,000 g for 10 min (may need to spin 2X) 
6. Remove DOC Soluble fraction and keep 
7. WASH Insoluble fraction 3x with Lysing reagent to further purify 
8. Solubilize DOC insoluble fraction in DOC Solubilizing Solution (50 µl) 
 
Protein Quantification 
1. Run micro-BCA Assay (see page 66 of lab book 03) 
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SDS-PAGE, TRANSFER (day 2) 
1. prepare protein marker and FN positive control 
a. marker is kept by whom ever ran last gel 
b. FN control = load 1µg (1µl) concentrated pFN  
c. Put samples into Gel loading buffer (6X) if needed, add water to make 
up volume in behalf of sample, to dilute 
d. Boil samples for 10 min 
e. Prepare 500 mL 1X running buffer (dilute 5X w/ water) 
f. Assemble gel box (cassettes face inward with tape removed, there is a 
blank if running only one gel) 
i. Fill middle with running buffer and outer channel at least ½ way 
with buffer 
g. Load samples onto GEL with long GEL loading pipette tips 
i. Include marker and FN control 
h. Run Gel  
i. 90 V in Stacking Gel (~30 min) 
ii. 115-230 V in separating gel (few hours) 
 
Protein Transfer 
1. prepare transfer buffer 
a. 100 ml 10 X Tris Glycine, 2.5 mL 10% SDS, 150 ml MeOH, water up to 
1L 
2. prepare transfer member and filter paper 
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a. cut PVDF transfer membrane to size of gel (do not handle, use 
tweezers) 
b. pre-wet membrane with MeOH for 30 sec, rinse in di water, soak in 50-
100 mL transfer buffer for several minutes 
c. cut filter paper to gel size and soak in transfer buffer before use 
3. prepare blotting pads 
a. soak blotting pads in buffer before use and remove all bubbles before 
use  
 
LOAD CATHODE CORE 
For two gels       
 Anode core (+)  TOP 
  Blotting pad (2) 
  Filter paper (2) 
  Transfer membrane 
  2nd gel 
  filter paper (2) 
  blotting pad 
  filter paper (2)  
  transfer membrane   
  1st gel   
filter paper (2)  
blotting pad (2) 
for one gel, replace with 
blotting pad 
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 Cathode core (-)   BOTTOM 
 
- Align plate of chamber and hold over buffer chamber, squeeze together and 
place into chamber 
- close the clamp 
- fill chamber with transfer buffer  
-attach lid and run at 30V for 90 min.  SET TIMER!!! 
-Prepare Blotto/Tween blocking buffer  (store in fridge) 
 5% non-fat dry milk in PBS w/o ions + 0.02% azide + 0.2 % tween 20 
  1L: 50 g milk, 20 mL 1% azide; 2 mL tween 
-dry membrane on paper towel for 5 min (protein facing up) 
-mark ladder with a pencil 
-rinse membrane several times with di water 
-block over night with blotto/ tween in fridge (4o C) 
 
 
DAY 3  Antibody blotting, ECF imaging 
 
Incubate in primary antibodies for 1h at room temperature, rocking  (use 10 ml 
and save solution) 
 Rb α-FN  1:1000 min 
 
Prepare tween for washing 
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10X TBS-Tween:  1L: 24.4 g Tris Base, 80g NaCl, pH to 7.6; 10 mL 
Tween 20, fill to 1L 
 
Wash membrane 2X with TBS-Tween 
Rock in TBS-Tween for 15 min 
Rock in TBS-Tween 2X for 5 min each 
Incubate in secondary antibodies 
 α- Rb AP  1:10,000  in blotto 
Wash membrane 2X with TBS-Tween 
Rock in TBS-Tween for 15 min; then Rock in TBS-Tween 2X for 5 min each 
EFC imaging 
 --ECF substrate is stored in the -80C 1B6 (stock is 0.6 mg/mL) 
 --Use 1 mL per membrane 
 --Spread evenly on transparency (above my bench) 
--Allow excess buffer to drip off membrane and lay face down onto the 
ECF.  Careful to have no bubbles.  DO NOT TRY TO MOVE ONCE 
DOWN, WILL CAUSE SMEARING!!!   
-- let react for 5 min 
--dry membrane on paper towel 
 




--Use the FLA Fluoro 2340 plate (put into machine) 
--place membrane face down on the upper left corner  
--lay transparency over the membrane to flatten 
 
Image software 
--launch FLA 3000 from desktop 
--Sample Mode: Fluor 473, Filter Y520 
--16 bit gradation, 50 resolution, F10 sensitivity 
 
 
modify in Image Ganger (??) 
 open file  image  range scope  move lines to modify contrast 
  save as bitmap file to a zip! 
 
Example:    DOC insoluble Reduced 
 










 The assembly of fibrillar COL matrices was examined using FITC-labeled 
type I collagen.  This was the best method for examining COL assembly since 
anti-COL antibodies failed to stain properly.  The COL antibodies that I tried were 
primarily for denatured COL and did not bind COL for IF staining. However, there 
is a wide body of literature using FITC-labeled COL to visualize COL matrix 
assembly.  This can even be quantified real time with live cells. The biggest draw 
back to this procedure is that the COL must remain in acidic pH or it will self-
assemble and form gels.  At high concentrations (when added to media) this will 
also occur.  I found this to be a problem as low as 5 µg/ml in media.  To prevent 
self-assembly, to introduce FITC-COL to the culture media, a media change was 
required.   
 
1) Following 24 h of culture, media was replaced with equal volumes of fresh 
culture media (37 oC) and culture media supplemented with FITC-labeled 
type I collagen (25 oC, Chondrex, Inc., Redmond, WA) to give a final 
concentration of 1 µg/ml.   
2) Following additional 24 h incubation with FITC-collagen, substrates were 
fixed and stained for FN as described above. 





Cell Differentiation:   
1) Monolayers were assembled as described above on 25 mm circles 
2) Low passage MC3T3-E1 osteoblasts were seed on functionalized 
monolayers and on COL-coated TC plastic @ 200 cells/ mm2  
(preferably in mineralized 10 % FBS, 1% PS, in α-MEM)  seeding day = 
D(0) 
3) On D(1), D(3), and D(5) media was exchanged with supplements;  50 
µg/ml L-ascorbic acid and 2.1 mM sodium β-glycerophosphate. 
4) On day 7, media was aspirated and and samples were washed 2x with 
cPBS (carefully, or cells will delaminate). 
 
Alkaline Phosphatase Activity: 
1) Add 500 ul of 50 mM Tris-HCl (pH 7.4) to each well. 
2) Scrape and add to 3.5” plastic test tube 
3) Sonicate each sample 2 x 10 sec @ 5.5-6.0 amps 
4) Transfer to 1.5 mL epindorf tube 
5) Centrifuge >10,000g for 5 min 
6) Pellet will form on the bottom;  transfer all but pellet to fresh tube 
7) Run µBCA on each sample to use equal amounts of total protein for 




 Micro BCA 
1) Get 96 well TC plastic dish from TC room 
2) Left three columns get serial dilutions of BSA (start with 1mg/ml) 
3) Any well that will have sample gets 45 µl of diH2O, and 5 ul sample 
(1:10 dilution) 
4) From Pierce micro BCA kit, mix 25:24:1  part A:B:C with enough 
volume for 50 µl per well (including serial dilutions) 
5) Put in incubator for 1 hr. 
6) Read on Levenston plate reader with an absorbance of 562 nm. 
 
 APL Activity 
1) In a 96 well black dish, make serial dilutions of ALP (stock in 3A5, -20 
oC) 
2) 2.5 ul of stock with 97.5 ul di H2O; (gives 0.025 ug/ul) 
3) 160 ul PBS with 40 ul of above to get 200 ul of 0.005 U / ul ALP (U = 
unit, 1 U = 1 umol / min) 
4) 50 ul of #3 to each of the top three wells for serial dilution 
5) 25 ul of PBS to all other wells of the serial dilution (and where sample 
goes), then do the serial dilution with 25 ul 
6) Subtract volume need from sample from each sample well and add 
sample (in volume to give equal 2.5 ug of protein to each well) 
7) 100 ul of MUP solution to each well  (see ELISA for more details) 
8) 1 h incubation under foil, in incubator if desired 
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9) Read in plate reader Excite =  360, Emission = 465; gain 40-60 
     
 Gene Expression 
The procedure for the analysis of data and work up of samples takes multiple 
days and is broken up as so in the following protocol.  Some days can be 
combined to save time, but days get very long with high sample numbers due 
to time intensive steps. 
“Day #1 Cell Lysing” 
1) Monolayers were assembled as described above on 25 mm circles 
2) Low passage MC3T3-E1 osteoblasts were seed on functionalized 
monolayers and on COL-coated TC plastic @ 200 cells/ mm2  
(preferably in mineralized 10 % FBS, 1% PS, in α-MEM)  seeding 
day = D(0) 
3) On D(1), D(3), and D(5) media was exchanged with supplements;  50 
µg/ml L-ascorbic acid and 2.1 mM sodium β-glycerophosphate. 
4) On day 7, media was aspirated and samples were washed 2x with 
cPBS (carefully, or cells will delaminate). 
5) In PRC room, add 350 µl of RLT Buffer: β-mercapto ethanol (100:1 
mixture) 
6) Scrape with cell scraper and put into purple two-part QIA Shedder 
tube. 
7) Spin 2 min at max speed in centrifuge to homogenize 
8) Remove purple top and replace lid; then place in freezer in -80 oC. 
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 “Day #2 –RNA Purification” 
1) Thaw tubes from above 
2) Add 350 µl of 70 % EtOH (made with sterile water) 
3) Pipette up and down to “homogenize” and then transfer to the 
RNeasy mini columns (pink) 
4) Centrifuge 15 sec @ >10,000 rpm (only RNA should stay on column, 
but some DNA could) 
5) Pour out what goes through the column 
6) Add 350 µl RW1 to each tube and centrifuge for 15 sec at >10,000 
rpm to rinse, toss what goes through 
7) Make mixture of 10 µl DNase I stock with 70 µl RDD buffer per 
sample.  Mix gently by inverting the tube several times. 
8) Place 80 µl directly onto each membrane and let incubate at room 
temperature for 15 minutes. 
9) Repeat step 6 
10) Transfer columns to fresh collection tubes and put 500 µl RPE buffer 
onto each column and centrifuge for 15 sec @ >12,000 rpm, toss 
flow through 
11) Add another 500 µl RPE buffer and spin 2 min @ > 12,000 rpm 
12) Transfer column to lock-cap epindorph and add 40 µl RNAse free 
water directly to the filter.  Spin 1 min > 12,000 rpm to elute RNA 
13) Cap and store in the -80 oC. 
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 “Day #3 Spec RNA to Determine the Concentration” 
1) Use the Levenston U.V. Spectrophotometer to determine the 
concentration of each sample (DNA/ RNA spec at a wave length of 
260 nm). 
 
“Day #4 Real Time PCR” 
1) Use template to determine how much RNA (volume) is needed for 1 
µg RNA to make equal amounts of cDNA 
2)    Used B.K.’s standards and primers. 
3) Set up a 96-well tube in PR trays w/ 8-joined tubes for each row 
4) Columns 1-3 get 1 µl each of standard in the top spots and do serial 
dilutions 
5) Rest of tubes get 1 µl of above cDNA 1 µg solution  
6) Put 29 µl of MMA Solution in each well (Primers (F + R), Water, and 
Buffer) 
7) Bring to PCR room 
 
“In PCR Room” 
1) Use the top computer (the MAC) 
2) Sequence Detector V. 1.7a 
3) New plate 
4) Dye Layer  Sybr 
5) Thermal Cycler Rxn  (30 µl) 
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6) Sample Type Set up 
a) All tabs = None 
b) Except standard = sybr 
c) Unknown = sybr 
d) Temp = sybr 
e)       Quencher;  None      OK  
7) Analysis    Analyze 
8) Viewer:  Rxn vs Cycle 
9) Double click on the X- Axis 
  Max value  > 15  
         Set baseline before first take of curve (before increase in the curve,          
 baseline region) 
   -update calc. 
  Change threshold 
   Scroll screen, click, and drop 
   Click OK 
   Close 
   File  Export  Results   Desktop 
  ***    Use template to determine amounts  
 
Cell Differentiation:  Von Kossa Staining for Matrix Mineralization 
1) Following 14 days of culture, cells were fixed in 70% ethanol, rinsed 
and stained by von Kossa.   
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2) 5% AgNO3 was added to each dish and plates were incubated under 
uniform light exposure for 30 min.   
3) The stain was then fixed in Na2SO3 for 2 min, rinsed and dried.   
4) Plates were scored for percent mineralization using Image Pro Plus 
image acquisition and analysis software (Media Cybernetics, Silver 
Springs, MD).   
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